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Abstract 
Anjum Hajat: Do the wealthy have a health advantage? An investigation of wealth as a 
measure of socioeconomic status 
(Under the direction of Jay S. Kaufman) 
 
 
Background: In the health literature, wealth is often overlooked as a measure of 
socioeconomic status.   
Objectives: We explored the association between wealth and various health outcomes, 
namely: hypertension, obesity, smoking, self-reported general health status (GHS) and 
mortality. 
Methods: We used data from the Panel Survey of Income Dynamics (PSID), a longitudinal 
study of a nationally representative US population.  PSID data from 1984 to 2005 were used 
to evaluate the association between wealth and mortality and GHS and data from 1999 to 
2005 to explore the relationship between wealth and hypertension, smoking and obesity.  
Inverse probability weights were employed to handle time-varying confounding and to 
estimate both relative and absolute measures of effect.  Wealth was defined as inflation 
adjusted net worth and specified as a 6 category variable: a category for those with less than 
or equal to 0 wealth and 5 quintiles of positive wealth.    
Results: In the fully adjusted model, the risk of becoming obese was inversely related to 
wealth; there was a 40% to 89% higher risk of becoming obese and 11 to 25 excess cases of 
obesity (per 1000 persons) among the less wealthy groups relative to the wealthiest quintile.  
Smoking initiation had a similar but more moderate effect, while hypertension incidence had 
a weak association with wealth, showing fewer excess cases (between 4 and 9) among the 
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less wealthy groups.  There was a 17% to 54% higher risk of falling into poor health and 6 to 
22 excess cases of poor health (per 1000 persons) among the 4 less wealthy groups relative to 
the wealthiest quintile.  The overall wealth-mortality association revealed between a 25% and 
83% increased risk and between 2 and 5 excess cases of death (per 1000) among the less 
wealthy compared to the wealthiest. 
Conclusion: There is a strong inverse association between wealth and incidence of obesity, 
poor health status and mortality, a moderate inverse association between wealth and smoking 
initiation and a weak inverse association between wealth and hypertension incidence.  
Wealth is a useful measure of SES and should be considered by future health researchers.   
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Chapter 1 
Introduction to wealth 
 
The connection between health and socioeconomic status (SES) is well established.  
From as early as the 17
th
 century scientists have observed that the poor are more susceptible 
to death and disease than the rich.  In modern epidemiologic practice, many health 
researchers give little thought to which measure of SES would be best for their population or 
study question.  SES is usually measured with income, education or occupation; while the 
use of wealth as a measure of SES is relatively rare.  There are, in fact, several reasons why 
wealth may be a better measure of SES and should be considered as a measure of SES for 
future health studies.  This dissertation investigates the association between wealth and 
various health outcomes.   
Definitions & theories 
Wealth is defined as a household’s stock or storehouse of resources (Keister 2000).  
Income, on the other hand, is defined as the flow of resources into the household and 
consumption as the flow of resources out of the household.  Savings is the difference 
between income and consumption and is transformed into wealth (through the purchase of 
cars, houses, stocks and bonds or the reduction of debt).   Thus by definition income and 
wealth are related but separate constructs.   
There are 3 major theories about household accumulation of wealth.  The first, known 
as the consumption model, posits that the purpose of wealth is for future consumption (1).  
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This model, developed by economists, has dominated the literature on wealth and to a large 
extent has shaped the definition and measurement of wealth (1).  The consumption model 
indicates several different roles that wealth can plan.  First, wealth can function as a store of 
value, which allows households to smooth consumption over time.  In periods where income 
is high, families can save thus accumulating wealth and during times when income is 
insufficient families can use wealth to sustain consumption.  In addition, wealth is a form of 
insurance, also known as “precautionary savings”, which may be needed for emergencies or 
unexpected costs.  And lastly, wealth can generate income through capital.  Using wealth to 
purchase machines or skills will eventually increase income and generate future wealth.   
A second theory related to wealth is social stratification.  Social stratification theorists 
believe that assets are used mainly in perpetuating social and economic inequalities from 
generation to generation.  Inheritance and bequests play a major role in maintaining social 
class, thus are critical to this perspective (2).  Lastly, the assets-for-development perspective 
maintains that assets can be used for capacity building, thus they are a tool for socioeconomic 
development (1).   
Several individual and household level factors impact wealth accumulation as well.  
The household’s position in the life course dictates the purpose of their savings.  For 
example, older individuals may be saving for retirement, while young families may be saving 
for their children’s college education.  In addition, social class dictates a household’s 
perspective on savings.  Comparing the wealthy to the middle-class and poor, several 
differences relating to wealth accumulation become immediately apparent.  First, the middle-
class have a different motivation for saving money compared to the wealthy.  They save 
primarily for retirement, emergencies and large consumer purchases, while the wealthy save 
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primarily for future investment.  Unfortunately, the poor make little progress in saving any 
money at all.  These savings motivations help the wealthy continue to accumulate wealth 
while doing little for the middle-class and much less for the poor.   
Advantages of wealth  
There are several advantages to using wealth as a measure of SES.  First, since it is 
less subject to fluctuations over one’s lifetime, wealth is often a more stable measure of SES 
than income.  The stability of wealth comes from the fact that it is often inherited over the 
generations thus reflecting a historical accumulation of assets.  However, it should be kept in 
mind that at certain times of the life course wealth is meant to be drawn upon or depleted 
(during sickness, emergencies or retirement).  During these times, wealth is serving one of its 
chief purposes to act as a store of resources thus ensuring minimal change in consumption 
during difficult times.   
In addition, wealth may be a better measure of social hierarchy compared to other 
SES measures (3).  Wealth buys economic security, political power, social prestige and 
educational or occupational opportunities in a way that income alone may not allow (4, 5).  
That is, wealth encompasses economic circumstances as well as prestige and status.  In 
Thomas Shaprio’s book The Hidden Cost of Being African American he posits that wealth is 
used by many white families to secure their social position in society (2).  For example, 
assistance with down-payments on homes, college tuition and college savings funds for 
future generations can help struggling middle-class families maintain the position their 
parents held.  Social stratification researchers also pay special attention to home-ownership 
as an important component of a household’s assets.  Neighborhood residence affords families 
access to high quality schools and efficient social services, thus furthering the use of assets to 
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maintain social position (1).  If Shapiro’s theory is true, the use of wealth as a measure of 
SES may provide a more nuanced measure compared to others.   
Finally, wealth may be a better measure of one’s economic situation at various points 
in the life course.  For example, during times of unemployment or illness when income is 
lost, wealth may help maintain living standards.  During these times, measures of 
employment status or income may misrepresent an individual’s economic situation.  Some 
studies have shown that SES measures are not interchangeable; instead they may work 
through different mechanisms at different times in the life course (6, 7).  For example, wealth 
may be an especially good SES measure for older populations, when income is limited or 
absent (5, 8).  In fact, several studies have shown a strong association between wealth and 
health in the elderly population (9-11).  Thus some have posited that wealth works 
independently of income to impact health (8).  
Issues in wealth measurement  
Wealth is not often used in health studies because it is difficult to measure effectively.  
A thorough assessment of wealth would require asking several sensitive questions about the 
value of personal property, debt and financial instruments.  Since wealth data are self-
reported and difficult to validate, the possibility of poor measurement exists.  Interestingly, 
the underestimation of assets by the wealthiest Americans has limited our ability to 
understand the true disparity in wealth that exists in the US (12).  In the health literature, 
measures of wealth are not consistent and are sometimes simplistic; thus making 
comparisons across studies difficult and masking potential associations between wealth and 
health outcomes (8).     
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For example, several health studies use questions on home ownership (yes/no) as a 
proxy for wealth.  Other studies rely on a single question to measure wealth, asking 
respondents to estimate their total assets minus any liabilities.  Research has shown that using 
fewer items results in significant underestimation of wealth (8).  Instead, using multiple more 
detailed questions about specific assets is likely to produce the most accurate picture of 
wealth.  Clearly, many health studies do not have the luxury of asking many detailed 
questions on wealth, a variable most likely used as an SES adjustment.  Fortunately, work is 
underway to develop a set of questions that can be used to ascertain wealth specifically for 
health studies (13).  
Even in studies that measure wealth well, there is a lack of consistency in the 
definition of wealth.  One common point of debate is whether to include or exclude the value 
of one’s home.  This reflects the distinction between net financial assets and net worth.  
Assets refer to the immediate liquid resources available in times of need, thus this measure 
excludes home equity.  Net worth, on the other hand, refers to resources available to the next 
generation and for future consumption, thus including home equity (2).  The appropriate 
measure depends on the study question at hand.  In addition, some researchers include future 
pension and social security assets in the calculation of family wealth, while others prefer to 
count this as income only when it is actually received (14).  More broadly, the issue of future 
pension income changes a household’s expectations about retirement.  If families can count 
on a consistent pension or social security income they will not need to draw on wealth stores 
as much as families who do not have such a luxury.  This difference in pension incomes 
between households implies the need to somehow account for this household characteristic. 
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One component of wealth that remains unmeasured is education.  Although it does 
not take the same form as the other forms of wealth, education is pivotal in generating 
income.  The contribution of education to younger individuals is likely greater than its 
contribution to older individuals, thus the young tend to have their wealth systematically 
underestimated.  Controlling for age and education in all models dealing with wealth is thus 
essential. 
An additional wealth measure, asset poverty, deserves a brief mention.  Researchers 
and policy advocates generally focus on income poverty as a measure of deprivation, with 
much less attention paid to the concept of asset poverty.  Asset poverty can be defined in 
many ways.  One common approach is to assess whether or not families have sufficient funds 
to maintain their households for up to 3 months.  The choice of 3 months reflects the average 
length of unemployment, when individuals are between jobs (1).  Asset poverty tends to be 
more persistent than income poverty, making it more difficult to move out of asset poverty.  
Asset poverty could be a useful addition to health studies interested in better understanding 
the effects of financial deprivation.    
There are several large longitudinal studies that collect high quality wealth data.  
Besides the Panel Survey on Income Dynamics (PSID), the Health and Retirement Survey 
(HRS) and the Survey of Income and Program Participation (SIPP) are other examples of 
longitudinal efforts which collect good wealth data.  (The study known as Asset and Health 
Dynamics of the Oldest Old (AHEAD) merged with HRS in 1998.)  The gold standard for 
wealth data comes from the Survey of Consumer Finances (SCF), which is a cross-sectional 
survey undertaken every 3 years.  The SCF oversamples wealthy households in order to 
provide a better estimate of household wealth in the US.  Given the skewed nature of wealth, 
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an assessment of the wealthiest Americans is essential to understanding the true distribution 
of wealth (5).  The SCF also asks many more detailed questions than other surveys resulting 
in more accurate wealth measurement.  The PSID, on the other hand, oversamples poor 
families; thus clearly underestimating the true distribution of wealth in the US.      
Wealth inequality  
Wealth inequalities in the US are considerable.  Historical data show the existence of 
inequalities in household wealth dating back to the 1920s, where the top 1% of wealth 
holders owned on average 30% of the total wealth (15).  Wealth inequality began increasing 
after 1979 and continued to increase through the 1980’s.  In the 1990’s inequality levels 
remained fairly consistent.  Recent estimates still indicate tremendous inequality.  A 2004 
estimate of the Gini coefficient for wealth was 0.81; the corresponding value for income was 
0.54 (16).  The Gini coefficient falls between 0 (wealth is evenly distributed across the 
population) and 1 (a single individual holds all the wealth).  Given this interpretation, it is 
clear that wealth inequality in the US is far more extreme than income.  Put in different 
terms, in 2004 the top 1% of wealth owners owned about 33% of the total wealth, while the 
top 10% owned about 70% of total wealth (16), a more skewed distribution than found in 
other developed nations (15). 
Looking at the portfolios of different social classes also sheds light on the nature of 
wealth inequality.  Most middle-class wealth is held in homes (about 60%) and in cash 
accounts (10%) compared to the wealthy that hold only a small amount of their assets in their 
homes (6%) but more in stocks (30%) and business assets.  Among the middle-class and poor 
there is a much larger burden of consumer debt compared to the wealthy.  Consumer debt 
does not allow for much savings and simply prolongs the process of consumption (5).   
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Wealth inequalities also fall strongly along racial lines.  According to the Census 
Bureau in the year 2000 non-Hispanic whites had a median net worth of $67,000 compared 
to $6,166 for non-Hispanic blacks and $6,766 for Hispanics (17).  Whites have more assets in 
all major subcategories (home equity, financial assets and real assets), but the differences is 
largest in financial assets and smallest in home equity (18).  Since financial assets are more 
liquid than the others, white families have more resources in times of emergency.  It should 
be noted that disparities exist within race groups as well, but the between race wealth 
differences are even larger (18).   In addition, there is little room for wealth mobility in 
America.  Most families are not able to accumulate enough wealth during their lifetimes to 
show any appreciable gains in wealth.  Thus the advantages the wealthy have, primarily from 
inheritance, are perpetuated because wealth is difficult to accumulate (5).  
   
 
Chapter 2 
Critical review of the literature 
 
WE will briefly review the existing literature for each of the health outcomes studied 
in this dissertation.  Tables 1 and 2 provide a list of studies using longitudinal data to explore 
the relationship between wealth and smoking, obesity, hypertension, general health status or 
mortality.  Most past studies used cross sectional data to explore the relationship between 
wealth and CVD risk factors (7, 16, 19-28) and the relationship between wealth and general 
health status (7, 11, 16, 29-32).    It should be noted that several other health outcomes, not 
discussed here, have also been studied in relation to wealth.  Researchers often use functional 
status as a health outcome, given the effectiveness of wealth as an SES measure for elderly 
populations.  Other health outcomes such as depression and several healthcare utilization 
measures (e.g. physician visits and hospital stays) have also been found in the literature (8).    
Smoking 
The literature on smoking and wealth consisted mostly of cross-sectional studies of 
European or Australian populations (22, 26, 28) with 1 study of a US population (16).  All 
cross sectional studies consistently found that the least wealthy had a higher prevalence of 
smoking (16, 22, 26, 28).  One longitudinal study was interested in the economic effects of 
smoking (wealth was the outcome and smoking the main exposure); Zagorsky found that 
heavy smokers had 200% and light smokers had 50% less wealth compared to non-smokers 
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after adjusting for other demographic and SES factors (33).  To my knowledge there have 
been no longitudinal studies where smoking was the health outcome and wealth the exposure.   
Obesity 
Few studies have looked at the relationship between obesity and wealth.  All the 
studies described below use self-reported height and weight to calculate BMI.  One cross-
sectional study of a US population found a negative association between wealth and BMI, 
only among women (20).  Another US study found no association between wealth and BMI, 
however wealth was crudely measured (24).  A cross-sectional study of a British population 
found a negative association with wealth, again only among women (7), while a recent 
German study compared those with excess debt to those without debt and found those in debt 
to have higher odds of obesity (23).   
Two studies by Zagorsky conducted longitudinal analyses using the National 
Longitudinal Survey of Youth.  These studies specified wealth as the main outcome and BMI 
as the exposure and found a strong association: increasing BMI resulted in decreasing wealth 
both overall and among black and white women (34, 35).  The covariate-adjusted results 
indicated that for every 1 point increase in BMI, net worth fell on average $1000 (34).  The 
largest decline in wealth was seen among white women where $1800 was lost with every 1 
point increase in BMI, followed by black women, where the decline in wealth was close to 
$600 (35).  To my knowledge no longitudinal studies have looked at the effects of wealth (as 
the exposure) on obesity (the outcome).   
Hypertension 
Several studies have assessed the association between hypertension and wealth; with 
the exception of 1 (the study by Rooks and colleagues) all have used self-reported 
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hypertension data.  Several cross-sectional studies found strong inverse associations between 
wealth and hypertension (7, 19, 21, 27), while another found no association between wealth 
and hypertension; however wealth was measured crudely (25).  Similarly, a longitudinal 
analysis of an elderly population in the US showed no causal link between low wealth and 
increased incidence of hypertension (36).  Adams and colleagues used the Granger test of 
causality to make this claim, a common method in econometrics used to understand if one 
time series predicts another.  The authors did not, however, attempt to uncover the true causal 
structure of the relationship between wealth and hypertension (36).   
Table 1. Longitudinal studies of the health-wealth relationship for CVD risk factors 
Author 
(year) 
Database Wealth measure Health measure Results 
Zagorsky 
(2004) 
NLSY, 
1984 to 
1998 
10 asset categories 
minus debt, continuous 
net worth variable 
excluding top 1% of 
wealth holders and log 
transformation of net 
worth 
Smoking 
(heavy, light 
and non-
smoker) 
Heavy smokers and 
light smokers had less 
wealth compared to 
non-smokers 
Zagorsky 
(2005) 
NLSY, 
1985 to 
2000 
10 asset categories 
minus debt, continuous 
net worth variable 
excluding top 1% of 
wealth holders and log 
Obesity (self-
reported height 
and weight) 
Increase in BMI results 
in a large decrease in 
wealth for white 
women, a small 
decrease for black 
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transformation of net 
worth 
women and white men 
and no association for 
black men 
Zagorsky 
(2004) 
NLSY, 
1985 to 
2000 
10 asset categories 
minus debt, continuous 
net worth variable 
excluding top 1% of 
wealth holders 
Obesity (self-
reported height 
and weight) 
Increase in BMI by 1 
point results in decrease 
in wealth of $900 per 
year 
Adams 
(2003) 
AHEAD, 
1993 – 
1998 
11 asset categories 
minus debt, continuous 
variable transformed 
Hypertension 
(self-reported) 
No association between 
wealth and 
hypertension 
NLSY: National Longitudinal Study of Youth 
AHEAD: Asset and Health Dynamics of the Oldest Old 
General Health Status  
Most cross-sectional studies that have assessed the association between wealth and 
general health status have found a strong inverse association; that is higher wealth was 
associated with better health status (7, 11, 16, 29-32, 37).  Several longitudinal studies from 
the economics literature found some evidence that poor health causes low wealth; testing the 
mechanism in the opposite direction that epidemiologists do (36, 38, 39).  The study by 
Adams et al found limited evidence of the health to wealth association among an elderly US 
population.  Their results indicated that poor or fair health status among married men actually 
resulted in increased savings (36).  Hurd and Kapteyn found associations in both directions.  
Those in poor health had 16% less wealth relative to those in excellent health, while those in 
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fair health had 7% less wealth.  Assessing the relationship in the other direction, they found 
that the wealthy had a higher probability of remaining healthy over time (38).  Smith looked 
at the onset of mild and severe health problems and concluded that wealth declines by $3600 
with the onset of a mild health problem and by almost $17,000 with the onset of a severe one 
(39).   
Other research has concluded that the direction of the relationship is from wealth to 
health (38, 40, 41).  Shuey and Willson used PSID data from 1984 to 2001 and excluded all 
those that were in poor health at baseline.  They found strong evidence that greater wealth 
was associated with better health (41).  Rodriguez and colleagues found a wealth-health 
association only among white men and women, wealthy white women have 19% higher odds 
of being in good health and wealthy white men 36% higher odds (40).   A study by Meer et 
al, also using PSID data, employed an instrumental variable approach (inheritance is the 
instrument) and found that there is no short term effect of wealth on perceived health status.  
This study did, however, find an effect of very small magnitude when using traditional 
statistical approaches (42).   
Mortality 
Several US studies that used a reliable measure of wealth found a positive association 
between wealth and mortality (10, 43-47).  There are, however, 2 US studies that did not find 
an association with mortality (36, 48).  The study by Feinglass et al concluded the lack of 
association between wealth and mortality after 10 years of follow-up was a result of 
controlling for baseline health status, an important mediator in the wealth-mortality 
association (48).  In addition, Adams and colleagues tested specifically for the “absence of 
causal links from wealth to mortality” and found evidence to support the claim.  In addition, 
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they concluded that death of a spouse had a negative effect on the subsequent wealth of the 
surviving family members (36).  All the mortality and wealth studies published thus far, use 
wealth data from a single time point and follow participants for several years to ascertain 
mortality.  The longest follow-up period was 17 years, both from the studies using data from 
the NLSMM (10, 43) and the shortest was Attanasio’s study which had a 2.5 year follow-up 
period (47). 
Table 2. Longitudinal studies of the health-wealth relationship for general health status and 
mortality 
Adams 
(2003) 
AHEAD, 
1992 – 
1998 
11 asset categories 
minus debt, 
continuous variable 
transformed 
GHS Poor health causes low 
wealth only among married 
men 
Hurd (2002) HRS, 1994 
– 2000 
8 asset categories 
minus debt 
GHS Finds evidence in both 
directions: change in health 
status causes change in 
wealth AND change in 
wealth causes change in 
health status. 
Meer (2003) PSID, 1984 
to 1999 
9 asset categories 
minus debt 
GHS Wealth effects health but the 
magnitude is small.  Using 
inheritance as an instrument 
results in no association 
between wealth and health.  
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Thus they conclude there is 
no short-term causal effect of 
wealth on health. 
Smith (1999) HRS, 1992 
- 1996 
AHEAD, 
1993 - 1996 
See Adams and 
Hurd above 
GHS New episodes of poor health 
lead to lower wealth 
accumulation. 
Rodriguez 
(1999) 
NSFH, 
1987 – 
1992 
Assets and debts, 
log transformed 
GHS Assets were associated with 
good health among white 
men and women, but not 
among black men or women. 
Shuey 
(2008) 
PSID, 1984 
– 2001 
See Meer above. 
Log transformed 
and adjusted for 
inflation and 
household size 
GHS Greater wealth associated 
with better health. 
Mare (1990) NLSMM, 
1966 
 
10 asset categories 
minus debt, wealth 
specified as 
quartiles 
Mortality Less wealthy have higher 
mortality 
Menchik 
(1993) 
NLSMM, 
1966 
17 years of 
10 asset categories 
minus debt 
Mortality Less wealthy have higher 
mortality 
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follow-up  
Duncan 
(2002) 
PSID, 1984  
10 years of 
follow-up 
See Meer above Mortality Less wealthy have higher 
mortality 
Bond Huie 
(2003) 
HRS, 1992  
6 years of 
follow-up 
See Hurd above, 
log transformed 
Mortality Less wealthy have higher 
mortality 
Cunningham 
(2005) 
HCSUS, 
1996  
4 years of 
follow-up 
1 question minus 
assets, specified as 
5 categories 
Mortality Low wealth categories have 
higher risk of mortality, HR 
not significant for higher 
wealth categories 
Attanasio 
(1995) 
SIPP, 1984 
– 1987. 2.5 
yr follow 
up 
8 asset categories 
minus debt 
Mortality Less wealthy have higher 
mortality 
Feinglass 
(2007) 
HRS, 1992 
10 years of 
follow-up 
See Hurd above, 
specified as 3 
category variable 
(< 20
th
 percentile, 
20 – 60th percentile 
and > 60
th
 
percentile) 
Mortality After adjusting for baseline 
health status, no association 
between wealth and mortality 
Adams AHEAD, See Adams above Mortality Found an absence of a causal 
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(2003) 1992   
6 years of 
follow-up 
link from wealth to mortality 
AHEAD: Asset and Health Dynamics among the Oldest Old 
GHS: self-reported general health status 
HRS: Health and Retirement Survey 
PSID: Panel Survey on Income Dynamics 
NSFH: National Survey of Families and Households 
NLSMM: National Longitudinal Survey of Older Men 
HCSUS: HIV costs and service utilization study 
SIPP: Survey of Income and Program Participation 
 
   
 
Chapter 3 
Specific Aims 
 
The overall goal of this research is to better understand the magnitude and direction 
of the relationship between wealth and several health outcomes on both the absolute and 
relative scales using longitudinal data. 
Aim 1: Investigate the association between wealth and 3 cardiovascular disease risk 
factors: smoking, hypertension and obesity on the absolute and relative scales in the time 
period 1999 - 2005.  
Rationale:   One of the leading hypotheses for why the poor have worse health 
outcomes compared to the wealthy relates to the presence of chronic stress in the lives of the 
poor.  Cardiovascular disease risk factors were chosen as health outcomes because chronic 
stress has been hypothesized to result in more smoking, obesity and hypertension.  Thus the 
association between wealth and CVD risk factors has implications for the pathways by which 
low SES causes ill health.  Furthermore, very little work has explored the relationship 
between wealth and these health behaviors. 
Aim 2: Investigate the overall, gender and race specific association between wealth 
and all-cause mortality and self-reported general health status on the absolute and relative 
scales in the time period 1984 - 2005. 
Rationale: Many studies have used all-cause mortality and self-reported GHS as 
health outcomes when investigating the wealth-health relationship.  Using these commonly
   
19 
 
 used outcomes will allow this research to be directly comparable to past research.  In 
addition, the long follow-up time makes these outcomes of particular interest.  The known 
race and gender differentials in mortality require that these outcomes be looked at within 
strata of these demographic variables.   
 
   
 
Chapter 4 
Methods 
Population  
Data for this study came from the Panel Survey on Income Dynamics (PSID), a rich 
longitudinal study with up to 38 years of follow-up on a nationally representative sample of 
US households.  PSID began in 1968 and continues today.  It is intended to be representative 
of the non-institutionalized, civilian US population.  In 1968, PSID oversampled low-income 
African-American families from urban areas in the North and rural areas in the South.  A 
second sample, also collected in 1968, selected participants from the 48 contiguous states 
with an equal probability of selection.  All participants selected in 1968 were between the 
ages of 25 and 74.  For this study both samples were used (referred to as the PSID core).   
Over time, PSID has been forced to make changes to its original sample in an attempt 
to address the large and growing immigrant population.  A large number of Latino families 
(n=2,000) were followed from 1990 to 1995.  This sample was discontinued because it did 
not account for America’s growing Asian population and because of funding constraints.  In 
1997 a small sample of immigrant families (n=511) joined the study and have been followed 
ever since.   
As members of the original PSID families have children who in turn form their own 
family units, the new families are also followed.  PSID collects data on each member of the 
family unit, defined as all those living in the same household not including temporary 
roommates or visitors, however, more detailed information is collected on the head of 
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household (usually male), followed by his “wife” (either by marriage or cohabitation).  Since 
health data is only collected for the head and “wife”, they are of primary interest in this 
study.  As of 2005 there were more than 8,000 families enrolled in PSID, resulting in more 
than 15,000 individuals interviewed.  Today, most PSID families descend from the original 
sample and are either non-Hispanic black or non-Hispanic white.   
Data collection was done annually from 1968 to 1997, but since 1997, PSID has 
moved to a biennial data collection.  Currently all surveys are done via computer-assisted 
telephone interviews and lasts about 75 minutes.  Originally designed as a way to study the 
dynamics of income and poverty, PSID’s core content focuses on family economics and 
demographics.  Income data are a central part of the PSID’s core content and are collected at 
every wave for each person in the family that is older than 16 and earning some income.   
Variables 
Wealth: Main exposure 
Data collection on family wealth began as a supplement to the core and was funded 
by National Institute for Aging.  Currently wealth data are asked in every survey year.  
Wealth data were collected in the 1984, 1989 and 1994 (as supplements) and 1999 – 2005 
waves of the survey.  When measuring family wealth PSID takes into account several 
sources: net value of the respondent’s main home, other real estate, vehicles, any farms or 
businesses, stocks, IRAs and other financial instruments, cash accounts such as money 
market funds and certificates of deposit and other assets including value of estates, life 
insurance policies, pensions and inheritance. Any outstanding mortgage principal and other 
debts are subtracted from these assets.  Table 3 lists the questions from the wealth module in 
PSID.  Future social security income and pension income are not included as potential 
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sources of wealth because they are not a reliable liquid asset and are only available to 
individuals older than 65 years old.  Instead social security and pension incomes are 
incorporated into family income for those receiving either one.   
Table 3. Survey questions used to measure wealth in PSID, 1984 - 2005 
1. The next questions I will be asking are designed to give estimates of wealth of 
families in the United States and how this has changed in the last five years. In these 
questions when I refer to family, I mean your family living there with you. Do you (or 
your family living here) have any real estate other than your main home, such as a 
second home, land, rental real estate, or money owed to you on a land contract?* 
1a. If you sold all that and paid off any debts on it, how much would you realize on 
it? 
2. What about the value of what you (or anyone in your family living there) own on 
wheels? Including personal vehicles you may have already told me about and any 
cars, trucks, a motor home, a trailer, or a boat--what are they worth all together, 
minus anything you still owe on them?** 
3. Do you (or anyone in your family living there) own part or all of a farm or business? 
3a. If you sold all that and paid off any debts on it, how much would you realize on 
it? 
4. Do you (or anyone in your family living there) have any shares of stock in publicly 
held corporations, mutual funds, or investment trusts, not including stocks in 
employer-based pensions or IRA's?  
4a. If you sold all that and paid off anything you owed on it, how much would you 
have? 
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5. Do you (or your family living there) have any money in private annuities or 
Individual Retirement Accounts (IRAs)? 
5a. How much would they be worth? 
6. Do you (or anyone in your family living there) have any money in checking or 
savings accounts, money market funds, certificates of deposit, government 
savings bonds, or Treasury bills, NOT including assets held in employer based 
pensions or IRA's? 
6a. If you added up all such accounts (for all of your family living there), about how 
much would they amount to right now? 
7. Do you (or anyone in your family living there) have any other savings or assets, 
such as bond funds, cash value in a life insurance policy, a valuable collection for 
investment purposes, or rights in a trust or estate that you haven't already told us 
about? 
7a. If you sold that and paid off any debts on it, how much would you have? 
8. Aside from the debts that we have already talked about, like any mortgage on your 
main home or vehicle loans – do you (or anyone in your family living there) currently 
have any other debts such as credit card charges, student loans, medical or legal 
bills, or loans from relatives? 
8a. If you added up all of these debts (for all of your family living there), about how 
much would they amount to right now? 
*Questions about the value of main home and money owed on it are derived from a series of 
questions in the housing section (Section A: Housing in 2005 survey).   
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**Questions about car loans are derived from a series of questions in the transportation 
section (Section F: Housework, childcare, food, vehicles and expenses in 2005 survey). 
Total family wealth is then calculated by PSID in 2 ways.  First, net financial assets 
add all the sources of wealth excluding home equity and second, net worth adds all the 
sources of wealth including home equity.  Net worth was used in all final models.  Given the 
importance of home values to the wealth portfolio of many middle-class American families, 
using net assets would have underestimated wealth for many PSID families.  The average 
annual consumer price index for urban households was used to adjust family wealth for 
inflation to 2000 dollars.  The final wealth variable was specified as a 6 category variable, 
where all families with less than or equal to 0 wealth were put in 1 category and the 
remaining 5 categories were quintiles of positive wealth.  A categorical wealth specification 
was decided upon in order to avoid the problems associated with the skewed nature of 
wealth.  Some researchers have undertaken log transformations of wealth; however, this still 
results in a skewed distribution.  To avoid violating the assumption of linearity the 6 category 
wealth variable was specified as 5 indictor terms in the final models, where the highest 
wealth quintile was the referent group. 
As wealth was the main exposure of interest in this dissertation, we tried several 
specifications of the wealth variable.  One specification of wealth tried early on was a 
categorical variable that used deciles of positive wealth and 2 additional categories, 1 for 
those with negative wealth and the other for those with 0 wealth.  Descriptive analysis with 
this 12 category wealth variable quickly revealed that the number of individuals in each 
category was relatively small resulting in large standard errors.  In addition, we also tried a 7 
category wealth variable.  This variable is similar to the one used in the final models except, 
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those with 0 wealth were separated from those with negative wealth.  Additional assessment 
of this 7 category variable revealed little difference in point estimates between these 2 low 
wealth groups and large confidence intervals around the point estimates, thus deeming the 
separation of the less than or equal to 0 wealth category unnecessary.  In addition, concerns 
about violation of the positivity assumption (having no respondents with a particular 
covariate pattern) further drove the decision to use the 6 category wealth variable.   
Health outcomes  
Data collection on the health of PSID participants began in 1984 with a short module 
assessing general health status, activity limitation, hospitalization and health insurance.  
Similar questions were asked in 1985 and then again in 1987 - 1997.  Substantial changes to 
the health module occurred in 1999, with the inclusion of questions regarding physician 
diagnosed conditions such as stroke, heart attack, cancer, asthma and hypertension, as well as 
questions about risk factors such as exercise, smoking, alcohol and self-reported height and 
weight.  A summary of the health outcomes used in this study are presented in Table 4. 
Smoking data were obtained from 1999 – 2005 of the PSID.  The questions used to 
ascertain smoking have not changed over the years and were used to categorize respondents 
as current versus non-smokers.  Respondents were first asked “Do you smoke cigarettes?”  
Those who responded “yes” were classified as current smokers.  Those who responded “no” 
were then asked “Did you ever smoke cigarettes?”  Those who responded “no” to the follow-
up question were considered never smokers, while those who respond “yes” were considered 
former smokers.  These 2 groups were collapsed to form the non-smokers group.   
Body Mass Index (BMI) is a commonly used metric to assess obesity or overweight in 
a population.  Using an individual’s height and weight, BMI was calculated by dividing 
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weight in pounds by height in inches squared and multiplying by a conversion factor of 703.  
BMI values that are less than 24.9 were considered normal weight; 25 to 29.9 was considered 
overweight and 30 and above was considered obese (49).  Self-reported height and weight 
were obtained from PSID in 1999, 2001, 2003 and 2005.  The questions are:  “About how 
much do you weight?” and “How tall are you?”   Respondents were asked to respond in 
pounds and inches, or as a second choice in kilograms and centimeters. For analysis, we were 
interested in the incidence of obesity, therefore normal and overweight individuals were 
grouped together. 
 Hypertension was ascertained from the following question:  “Has a doctor ever told 
you that you have or had high blood pressure or hypertension”.  This question was asked in 
the 1999, 2001, 2003 and 2005 waves of the survey.  Those with controlled hypertension 
should be captured by this question, as it asks about past diagnosis of hypertension.  Anyone 
responding “yes” to the question was considered hypertensive, and those who respond “no” 
were not.   
Self-rated general health status (GHS) is the respondent’s assessment of his/her 
current health status.  General health status was captured with the following question: 
“Would you say your health in general is excellent, very good, good, fair, or poor?”  The 
wording of this question has not changed since it was first asked in 1984.  GHS is available 
for 7 waves of the study 1984, 1989, 1994, 1999, 2001, 2003 and 2005.  Responses were 
dichotomized by grouping all respondents who indicated excellent, very good or good versus 
those who responded fair or poor. 
Mortality data was available through special contract with PSID because of its 
sensitive nature.  The mortality file was linked to the core PSID dataset by matching 
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respondents on their unique identification number.  Death was recorded as a possible reason 
for non-response.  The discovery of a participant’s death occurred during the following 
year’s interview with surviving family members or mail returned from the post office.  After 
a death was discovered, PSID used the National Death Index (NDI) to confirm the death.  
The death file included several variables on which the quality of the match with the NDI can 
be assessed: date of birth and death and place of both birth and death.  Social security 
numbers were not collected by PSID.  Additional discussion of the quality of the mortality 
data in PSID can be found in the discussion section of Chapter 6.    
Table 4. Outcome variables from PSID, 1984 - 2005 
Name Definition Source Form 
Mortality Respondent’s with a date of 
death were classified as dead; 
those without a date of death 
were considered alive 
PSID mortality 
file from 1968 - 
2005 
0 = alive 
1 = dead 
General Health 
Status 
Excellent, very good or good  
indicated good health; fair or 
poor indicated poor health 
status 
PSID core file 
1984 - 2005 
0 = good 
1 = poor 
Smoking Those who currently smoke 
cigarettes were considered 
smokers; those who used to 
smoke or who never smoked 
were non-smokers 
PSID core file 
1999 -2005 
0 = never or former 
smokers 
1 = current smokers 
Obesity ≤ 29.9 was overweight or 
normal weight 
≥ 30 was obese 
PSID core file  
1999 -2005 
0 = normal weight or  
overweight 
1 = obese 
Hypertension Respondents answering “No” 
to question on hypertension 
were not hypertensive, those 
PSID core file 
1999-2005 
0 = not hypertensive 
1 = hypertensive 
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answering “Yes” were 
hypertensive 
Covariates 
 The following confounders were included in this study: age, race, sex, education, region of 
residence, general health status, marital status, health insurance status and family income.  
Table 5 lists the baseline and time-varying covariates which were used in conjunction with 
each outcome variable.  A more detailed description of how each covariate was specified can 
be found in Chapter 5 and 6 below. 
Table 5. Baseline and time-varying covariates for each health outcome, PSID 1984 - 2005 
 Smoking Obesity Hypertension General 
health status 
Mortality 
PSID 
waves 
1999, 2001, 
2003, 2005 
1999, 2001, 
2003, 2005 
1999, 2001, 
2003, 2005 
1984, 1989, 
1994, 1999, 
2001, 2003, 
2005 
1984, 
1989, 
1994, 
1999, 
2001, 
2003, 
2005 
Covariates 
measured at 
baseline 
Age, race, 
sex, region, 
education, 
general health 
status, years 
Age, race, 
sex, region, 
education, 
general health 
status, years 
Age, race, sex, 
region, 
education, 
general health 
status, years 
Age, race, 
sex, region, 
education, 
years 
participated 
Age, race, 
sex, 
region, 
education 
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participated in 
study 
participated in 
study 
participated in 
study 
in study  
Time-
varying 
covariates* 
Income, 
marital status, 
health 
insurance 
status** 
Income, 
marital status, 
health 
insurance 
status 
Income, marital 
status, health 
insurance status 
Income, 
marital status 
Income, 
marital 
status, 
general 
health 
status 
*Baseline status of all time varying variables were also included in all models. 
**Health insurance status was not collected in 1984, 1989 or 1994. 
Region of residence was not available in the 1994 PSID, therefore, 1993 values were 
used in there stead.  In addition, several covariates had modest missing data (generally 
around 2%).  Data from the previous year was used to impute any missing data values for 
age, education, marital status, region, general health status and race.  For example, among 
those entering the study in 1984, 132 individuals were missing education data.  If those with 
missing data had participated in the 1983 survey, data from 1983 were used to impute these 
missing education values.  This reduced the amount of missing education data in 1984 by 
18%.   
As per the suggestion of a former committee member, religion was also explored as a 
potential covariate for the wealth health relationship.  Some sociological work has 
documented different wealth patterns among the various religious faiths (50).  Ultimately, we 
did not include religion as a covariate because the questions about religion in PSID did not 
   
30 
 
allow for the creation of meaningful religious groups.  Furthermore, the religion questions 
changed substantially from year to year of the survey. 
Person time was also included as a covariate in each model, except for mortality.  
Person time was calculated in years from baseline to the end of follow-up.  Some 
assumptions were made in order to calculate person time for those who were lost to follow-
up.   Each individual was given 1 person year for each year they participated in the study 
between 1984 and 1996.  For example, if someone entered the study in 1984 and their last 
interview was in 1990, they were assigned 7 person years.   The move to biennial data 
collection changed the way person time was calculated.  Individuals who participated for 
consecutive years were assigned 2 person years, but those that dropped out between 1997 and 
2005, were assigned 1 person year.  This was done because the exact date of drop out was 
unknown.  For example, if someone entered the study in 1992 and their last interview was 
2001, this individual was assigned 11 person years.  Since we know this individual did not 
participate in 2003, we can assume they were lost to follow up sometime after the 2001 
interview but before the 2003 interview.  The additional year was assigned to account for the 
uncertainty of drop out time.    
Statistical methods 
In epidemiology and related fields, marginal structural models (MSM) are 
increasingly used to handle time-varying confounding.  A variable is a time-varying 
confounder if it can be influenced by previous exposure and can subsequently influence 
future values of the exposure (51).  Figure 1 below depicts a simplified directed acyclic graph 
(DAG) of time-varying variables, where the vector of time varying confounders is 
represented by Lk and the main exposure wealth is represented by Wk.  The red line from W0 
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to L1 represents the influence of wealth at time 0 on the time-varying confounders and the 
second red line from L1 to W1 represents the subsequent influence of the time-varying 
confounders at time 1 on wealth at time 1.  Traditional methods may produce biased 
estimates in the face of time-varying confounding (51, 52), therefore, the use of MSM is 
recommended. 
Figure 1. Directed acyclic graph depicting time-varying confounding 
 
The use of inverse probability weights (IPW) is central to MSM.  Weighting creates a 
pseudopopulation where an individual can be represented as a fraction of oneself or more 
than once.  In this pseudopopulation confounding is controlled by eliminating the association 
between the confounders and the exposure (51).  The IPW can be informally described as the 
probability that an individual received their observed exposure history.  Calculating IPW is 
the first step in using MSM.  In this study IPW were calculated separately for each outcome 
because exclusion criteria resulted in different analytic populations.   
IPW are made up of 2 components.  The equation below shows the treatment weight, 
swi(t), which was modeled using an ordinal logistic regression where the outcome is the 6 
category wealth variable, A.  As indicated above, the highly skewed nature of wealth does 
not allow for the use of a continuous specification in the treatment weight model.  Some 
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MSM experts believe that the specification of exposure in the treatment weight model can be 
finer than the specification of exposure in the final model, but not vice versa.  This may 
better control for time-varying confounding (personal communication with Stephen Cole).  
Thus our use of the 6 category wealth variable in both the weighting and final models was 
necessary given the highly skewed nature of wealth would not allow for a continuous 
specification in the weighting model when wealth is considered the outcome. 
The participant’s covariate history is designated by .  The numerator of the 
treatment weight model includes all baseline covariates, V.  For the CVD risk factor model 
this includes baseline values for age, race, sex, education, region, income, marital status, 
general health status and health insurance status.  The denominator includes all baseline 
covariates, time-varying covariates (income, marital status, general health status and 
insurance) as well as significant interaction terms of baseline covariates, L(t).  Although the 
inclusion of the baseline covariates in the numerator and the denominator may seem 
redundant, it helps to reduce the variability of the weight avoiding a situation where a few 
observations contribute excessively to the weighted analysis.  In turn a less variable weight 
produces a final parameter estimate that has a smaller variance and is approximately 
normally distributed (51).  The treatment weight is defined as the conditional probability that 
the subject received his/her own observed level of wealth at each time point.  
 
 
The second component of the IPW, the censoring weight, , was modeled with 
logistic regression.  The outcome is defined as whether or not an individual was censored or 
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loss to follow up, C, where individuals who are lost to follow up are coded as 1 and 0 
otherwise.  The participant’s censoring history is designated by .  Individuals are censored 
at the last time point for which they have data.  The censoring weight is defined as the 
conditional probability that the subject remains uncensored up to time t and is presented in 
the equation below.   
 
 
The censoring and treatment weights were then multiplied to produce the final 
stabilized weight.  The stabilized weight thus incorporates all measured time-varying 
confounding.  The final binomial MSM is as follows, where V is the vector of baseline 
covariates:   
 
Notice the absence of time-varying covariates in this model.  The incorporation of the IPW 
makes the addition of time-varying confounders unnecessary.  The baseline covariates are in 
both then numerator and denominator of both weighting models effectively cancelling each 
other out, therefore, adding baseline covariates to the final model is necessary.  The 
parameter β1 is the causal risk ratio of wealth on smoking, obesity or hypertension, for 
example.   
Further discussion of the creation of IPW is warranted.  IPW are predicted 
probabilities which are calculated from the data.  Data must be formatted so that there is 1 
observation per time point per person.  Given this data structure, a different weight is 
calculated for each time point the individual participates in the study (the weight is time-
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varying).  Baseline and time-varying variables are assigned to each observation in the 
dataset.   
As stated above, the treatment weights were calculated from ordinal logistic 
regression, where wealth is the outcome.  Given that wealth is a 6 category ordinal variable, 
the model calculates the predicted probabilities for each level of wealth for each participant 
at each time point.  The predicted probability which corresponded with each participant’s 
observed wealth value for each time point was then calculated and extracted into a separate 
dataset.   
The goal of the weighting models is to produce the best predicted probability 
possible.  In order to achieve this goal variables should be specified flexibly and all 
significant predictors should be included.  Therefore, several interaction terms were added to 
the denominator of each weighting model.  Interactions between baseline variables had to be 
at the 0.35 significance level to be included in the denominator of the treatment and 
censoring weight.  Hierarchically specified models are not a requirement for prediction 
models, thus if one level of an interaction term was significant but another was not, only the 
significant term was retained.  The censoring weight models are similar to the treatment 
weight models; this is done for ease of fitting the models, but is not a requirement.  Predicted 
probabilities calculated from logistic regression are the censoring weights.  The predicted 
probability from the numerator models is then divided by predicted probability from the 
denominator models to produce the final IPW.   
At each time point, IPW should have a mean of 1 and a small range (53).  In our 
study the initial weights had a mean that was slightly greater than 1.  For example for the 
obesity model the overall mean of the IPW was 1.10, the smallest weight was 4.09 x10
-7
 and 
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the largest was 164.  Very large and very small IPW are generally a result of odd covariate 
patterns.  For example, if respondents had extreme fluctuations of income over the study 
period, this could result in excessively large or small weights.  In order to reduce the range of 
the weight, which ultimately reduces the variability of the final estimates, weights can be 
truncated (53).  In this study 2 percent of the largest and smallest weights were truncated to 
obtain better behaved IPW.  For obesity the weight corresponding with the 2
nd
 percentile 
becomes the minimum, 0.31, and the weight corresponding to the 98
th
 percentile becomes the 
maximum, 2.56.  The distribution of the trimmed and untrimmed weights is given in Figure 
2.  
Figure 2. Mean value of trimmed and untrimmed weights for each outcome 
 
Several weighting models were fit to determine which produced the best weights.  We 
started with the simplest weighting model, which includes age and income specified as 
continuous variables, all other covariates as indicator terms and no interaction terms, and 
moved to the most complex model which includes age and income specified as squared, 
cubed and spline terms and the inclusion of all significant interaction terms.  In general the 
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more complex weighting models produced the best weights (mean close to 1 and narrow 
range). 
One final detail involving the intercept of the weighting model should be discussed.  
The person-time specific intercept for all weighting models was estimated using a smoothing 
technique.  This is recommended to reduce the variability of the final weight (52).  A SAS 
macro, rcspline, was used to fit natural cubic splines (54).  For the CVD risk factor models, 
we used 3 knots placed at the 5
th
, 15
th
 and 50
th
 percentile of time.  Usually more knots are 
placed at the tails of the distribution, however in this study of CVD risk factors the time 
distribution was skewed making multiple knots at the high end of the distribution redundant.  
For the GHS analysis 5 knots were used; placed at the 5
th
, 27.5
th
, 50
th
, 72.5
th
 and 95
th
 
percentile.   
Assumptions 
Several assumptions must be tested and met in order to ensure the integrity of the 
model.  MSM are sensitivity to the assumption of positivity, which states there must be both 
exposed and unexposed individuals at every level of the confounders (53).  That is if it is 
impossible to be exposed at 1 or more levels of the confounders than positivity is violated.  In 
this study, it is feasible for some individuals to have low or no wealth regardless of the level 
of the confounders.  Although some may find it unlikely that an individual with high income 
would have low wealth, this situation may indeed be fairly common among persons with 
substantial debt.  In practical terms, the positivity assumption may be violated because of so-
called random zeros.  Continuous variables are especially sensitive to random zeros since it 
may be difficult to find both an exposed and unexposed person at every level of the 
continuous variable.  For categorical variables, however, collapsing similar categories may 
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help alleviate problems with random zeros.  We looked for the presence of random zeros 
among the categorical confounders and collapsed several categories as a result.   
 For continuous and ordinal variables we also checked the linearity assumption.  Since 
the weighting models are prediction models, violation of linearity is less important for these 
first stage models.  However, in the final models, linearity must be met.  Thus we assessed 
the linearity of baseline age and income in relation to each of the 5 health outcomes.  If non-
linear patterns were detected, the variables were specified as indicator variables to avoid the 
violation of linearity.  As noted above, the skewed nature of wealth required that it be 
specified as 5 indicator terms in order to avoid the violation of linearity. 
Clustering 
Since data for both heads of household and their partners was available from PSID, 
there was clustering by household.  Furthermore, given the longitudinal nature of the analysis 
data were formatted vertically (there was 1 observation per time point per person), resulting 
in additional clustering by individual.  Using the highest level of clustering (the household) 
produced results that control for both household and individual clustering (55, 56).  
Therefore, a family id variable was used to indicate the unit of clustering (with an 
independent correlation structure) thus obtaining robust standard errors.  As a check, we ran 
several models where individual level clustering was specified.  The standard errors for these 
models were very similar but, as expected, smaller than those from models where clustering 
at the household level was specified.  Table 6 provides a comparison of the standard errors 
from these 2 models for each category of wealth for 2 randomly selected outcomes.   
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Table 6. Standard errors for models with clustering at the family level versus the individual 
level 
  ≤ 0 
wealth 
Quintile 1 Quintile 2 Quintile 3 Quintile 4 
Obesity Family level 
clustering 
0.118 0.121 0.113 0.106 0.102 
 Individual 
level 
clustering 
0.115 0.117 0.110 0.103 0.097 
GHS Family level 
clustering 
0.101 0.093 0.093 0.085 0.081 
 Individual 
level 
clustering 
0.095 0.088 0.87 0.081 0.076 
Risk difference models 
Recently researchers have proposed methods for obtaining absolute measures of effect (i.e. 
risk difference) for MSM (57, 58).  We attempted 3 methods for calculated risk differences 
before a satisfactory risk difference model was found.  First, we attempted a method 
proposed by Westrich and colleagues (58).  This method calculated survival probabilities for 
each level of exposure by summing the inverse probability weighted number of cases and 
dividing by the total number of individuals in the pseudopopulation (i.e. the sum of the 
weights).  This quantity was then subtracted from 1 to obtain the survival probability.  The 
risks calculated from these survival probabilities effectively controlled for time-varying 
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confounding.  The problem with this method, however, is that it does not control for baseline 
covariates.  In our study, controlling for baseline covariates such as age, race and sex are 
essential to obtaining an unbiased estimate.  Therefore, after attempting various fixes to this 
method, we concluded it could not be used.   
Second, we tried running linear risk models.  These were general linear models which 
specified the identity link and the binomial distribution.  Although these models allow for the 
control of both baseline and time-varying confounders, several of these models did not 
converge.  Even after attempting to use starting value from the normal distribution, non-
convergence problems persisted.  Therefore, these models were also abandoned. 
 Lastly, we used a method common to economists, marginal effects.  Predicted 
probabilities from logistic regression were used to calculate risk differences.  In Stata, the 
post estimation command mfx calculated confidence intervals for these risk differences using 
the delta method (59).  Estimates were standardized to the covariate distribution of the total 
study population.  A full description of this method can be found in chapter 21 of the 
Econometrics textbook by William Greene (60).  
   
 
Chapter 5 
Cardiovascular disease risk factors and wealth 
Abstract 
Background: The use of wealth as a measure of socioeconomic status (SES) remains 
uncommon in epidemiological studies. When used, wealth is often measured crudely and at a 
single point in time.  
Objective: Our study explores the relationship between wealth and 3 cardiovascular disease 
(CVD) risk factors (smoking, obesity and hypertension) in a US population.  
Methods: We improve upon the existing literature by using a detailed and validated measure 
of wealth in a longitudinal setting. We used 4 waves of data from the Panel Survey on 
Income Dynamics (PSID) collected between 1999 and 2005. Inverse probability weights 
were employed to control for time-varying confounding and to estimate both relative (risk 
ratio) and absolute (risk difference) measures of effect. Wealth was defined as inflation-
adjusted net worth and specified as a 6 category variable: 1 category for those with less than 
or equal to 0 wealth and quintiles of positive wealth.  
Results: In the fully adjusted model, the risk of becoming obese was inversely related to 
wealth. There was a 32% to 77% higher risk of becoming obese among the less wealthy 
relative to the wealthiest quintile and 11 to 27 excess cases (per 1000 persons) among the less 
wealthy groups over 6 years of follow up. Smoking initiation had similar but more moderate 
effects; risk ratios and differences both revealed a smaller magnitude of effect compared to 
obesity. Of the 3 CVD risk factors examined here, hypertension incidence had the weakest 
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association with wealth, showing a smaller increased risk and fewer excess cases among the 
less wealthy groups.  
Conclusion: This study found a strong inverse association between wealth and obesity 
incidence, a moderate inverse association between wealth and smoking initiation and a weak 
inverse association between wealth and hypertension incidence. 
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Introduction  
The goal of this study was to explore the relationship between wealth and three 
cardiovascular disease (CVD) risk factors, smoking, obesity and hypertension; specifically, 
do less wealthy individuals have a higher risk of becoming obese, smokers or hypertensive.  
In epidemiological studies the use of wealth as a measure of socioeconomic status (SES) is 
uncommon.  Wealth is defined as the stockpile of financial resources amassed over the 
lifetime, while income is the flow of resources into the household at any given point in time 
(4, 5).   
There are several advantages to using wealth as a measure of SES.  First, since it is 
less subject to fluctuations over one’s lifetime than income, wealth is often a more stable 
measure of SES. Since wealth is often inherited over the generations it reflects a historical 
accumulation of assets.  Second, wealth may be a better measure of social hierarchy 
compared to other SES measures (3).  In addition to being an economic indicator, wealth 
buys political power, social prestige, and educational and occupational opportunities that 
income alone may not allow (4, 5).  That is, wealth encompasses economic circumstances as 
well as prestige and status.   
Finally, wealth may be a better measure of one’s economic situation at various points 
in the life course.  For example, during times of unemployment or illness when income is 
lost, wealth may help maintain living standards.  During these times, measures of 
employment status or income may misrepresent an individual’s economic situation.  Some 
studies have shown that SES measures are not interchangeable; instead they may work 
through different mechanisms at different times in the life course (6, 7).  For example, wealth 
may be an especially good SES measure for older populations, when income is limited or 
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absent (5, 8).  In fact, several studies have shown a strong association between wealth and 
health in the elderly population (9-11).  Given these examples, it is easy to understand how 
wealth can work independently of income to impact health (8).  
Wealth is not often used in health studies because it is difficult to measure effectively.  
A thorough assessment of wealth would require asking several sensitive questions about the 
value of personal property, debt and financial instruments.  Since wealth data are self-
reported and difficult to validate, the possibility of poor measurement exists.  Interestingly, 
the underestimation of assets by the wealthiest Americans has limited our ability to 
understand the true disparity in wealth that exists in the US (12).  In the health literature, 
measures of wealth are not consistent and are sometimes simplistic; thus making 
comparisons across studies difficult and masking potential associations between wealth and 
health outcomes (8).     
Most past studies used cross sectional data to explore the relationship between wealth 
and CVD risk factors (7, 16, 19-28).  Our study of wealth and CVD risk factors improves 
upon the existing literature by using a thorough and reliable measure of wealth (61) from a 
longitudinal study, the Panel Survey on Income Dynamics (PSID).  Our choice of PSID was 
motivated not only by its detailed wealth measurement, but also by a desire to evaluate the 
wealth-health relationship in a non-elderly adult US population.  Much work has looked at 
wealth and CVD risk factors in the elderly (7, 19-21, 25, 27, 36), but fewer studies have 
examined the effect of wealth on health in a population of established adults.   
Methods 
Data 
   
44 
 
PSID is a longitudinal study of the US population which began in 1968 and continues 
today.  Currently data are collected biennially.  Although PSID was designed to be 
representative of the non-institutionalized, civilian US population, survey weights were not 
used in this study.  The use of survey weights would have complicated the analytic method 
we used which also relies on analytic weights.  Thus results from this study are not 
generalizable to the broader US population.  Much has been written about the design and 
content of the PSID elsewhere (62).  Data for this study came from the 1999, 2001, 2003 and 
2005 waves of the PSID.  Regular data collection of the health module began in 1999 and has 
continued in each wave since.  Health questions were asked only of the head of household 
and his/her partner.   
Measures 
Health outcomes: The three health outcomes examined in this study, obesity, smoking 
and hypertension, were self-reported.  Obesity was derived from self-reported height and 
weight and was classified using a body mass index of 30 or higher.  Smoking status was 
derived from a series of questions on smoking behavior allowing participants to be classified 
as current, former or never smokers.  Lastly, hypertension was ascertained from a single 
question, “Has a doctor ever told you that you have or had high blood pressure or 
hypertension”.   
Wealth:  Family wealth was defined as total net worth, which includes the value of 
one’s primary home, farm or business assets, checking or savings accounts, vehicles, second 
homes, stocks and bonds.  Debt was subtracted from these assets.  All wealth data were 
adjusted for inflation using the 2001 consumer price index.  Wealth was specified as a six 
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category variable, where category one included all those that have negative or zero wealth 
and categories two through six were quintiles of positive wealth.  In the final models, wealth 
was specified as five indicator terms (i.e. dummy variables) to avoid violating the linearity 
assumption.    
Confounders: Other covariates included in this study were income, marital status, 
self-reported general health status, region of residence, age, education, race, sex and health 
insurance status.  Income was specified as a continuous poverty-to-income ratio using the 
annual poverty thresholds from the Census Bureau and accounting for number of people in 
the household.  In the final model, income was linearly related to obesity and smoking but 
required indicator terms to avoid violating the linearity assumption for hypertension.  Marital 
status was categorized as married (the referent group), never married or divorced, separated 
or widowed, and specified as indicator terms.  Self-reported general health status was 
dichotomized as excellent, very good and good versus fair and poor.  The three indicator 
variables for region classified state of residence as northeast, midwest or south; west was the 
referent group.  Age was linearly associated with hypertension, but due to convergence 
problems was specified as six indicator terms (30-34, 35-39, 40-44, 45-54, 55-64 and ≤ 65 
years old, referent was ≤ 29 years old).  The final model for obesity used two indicator terms 
representing less than or equal to 44 years old and 45-64 years old and the final model for 
smoking used less than or equal to 39 years old and 40-64 years old (referent group was ≤ 65 
years old for both models).   These categories were based on analysis that explored the shape 
of the relationship (e.g. linear, u-shaped etc) between age and obesity and age and smoking.  
Education was specified as two indicator variables, (< high school and high school degree) 
and greater than high school was the referent group.  An indicator variable for race included 
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all non-white participants, which in PSID consists mostly of African-Americans and the 
referent group was non-Hispanic white.  Lastly health insurance status was ascertained as a 
dichotomous variable indicating whether or not someone in the family had insurance.   
Statistical analysis 
Both absolute and relative measures of effect were used to estimate the adjusted 
associations between wealth and the three health outcomes.  Binomial marginal structural 
models (MSM) yielded adjusted risk ratios directly from exponentiated regression 
coefficients. Risk differences were calculated by taking the differences between predicted 
probabilities estimated from logistic regression models.  Variances for the differences were 
estimated by the delta method (63) via the marginal effects post-estimation procedures 
available in Stata version 10 (59).   Risk differences were taken holding all covariates at their 
mean values, which corresponds to standardization of the effect estimates to the covariate 
distribution in the total study population.  The final binomial MSM is shown below:   
 
MSM are an effective tool for analyzing data in the face of time-varying confounding.  
The major time-varying confounders of interest in this study were income, marital status and 
insurance status.  The main exposure, wealth, was also time-varying.  Sex, race, age, 
education, self-reported general health status and region were ascertained at baseline and 
treated as time-invariant.  Baseline values for all time-varying confounders were also 
included in the final MSM.  In the event that the binomial model did not converge, we used 
starting values from Poisson regression (64).    
Since data for both heads of household and their partners was available from PSID, 
there was clustering by household.  Furthermore, given the longitudinal nature of the analysis 
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data were formatted vertically (there was one observation per time point per person), 
resulting in additional clustering by individual.  Using the highest level of clustering (the 
household) produces results that control for both household and individual clustering (55, 
56).  Therefore, a family id variable was used to indicate the unit of clustering and to obtain 
robust standard errors. 
In creating the analytic dataset for this study, individuals who were obese, smokers or 
hypertensive at baseline were excluded, allowing for the analysis of incident cases.  In the 
smoking analysis, new smokers are either those who resumed smoking after quitting or those 
who initiated for the first time.  Given the age of this population, most new smokers resumed 
smoking rather than initiated.  Participants were allowed to enter the study at any point in 
time (between 1999 and 2003) as long as they participated for more than one year of data 
collection (i.e. each individual had to have at least two waves of data).   
Calculating inverse probability weights 
Inverse probability weights (IPW) are a key feature of MSM.  Time-varying 
confounding is controlled through the use of these weights (51, 52).  IPW were estimated 
from predicted probabilities obtained from logistic and multinomial models.  Logistic models 
were used to obtain censoring weights, where the outcome of interest was whether or not the 
individual was lost to follow-up at that time point (those who were lost to follow up were 
coded as one and zero otherwise).  The formula for the censoring weight is shown below:   
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Multinomial (i.e. proportional odds) models were used to obtain treatment weights, where the 
six category wealth variable was the outcome.  The formula for the treatment weight is 
shown below:   
 
Multiplying the treatment and censoring weights resulted in the final IPW.  Continuous 
variables, income and age (centered on the mean), were entered into the weighting model 
flexibly: as linear terms, squared terms and quadratic splines.  The numerator of the weight 
contains all covariates measured at baseline (age, race, sex, education, region, general health 
status, marital status, income and health insurance status) as well as baseline wealth while the 
denominator contains baseline and time-varying confounders (income, marital and health 
insurance status).  By including baseline covariates in the numerator of the weight, the IPW 
were stabilized thus producing smaller variances for the final estimates (52).   
We tested several weighting models.  Continuous variables were first tried as linear 
terms and then as higher order and spline terms.  Significant interaction terms were also 
included in weighting models.  Modeling continuous variables more flexibly (as higher order 
terms and splines) and excluding interaction terms proved to be the best weighting model.   
This decision was based on the distribution of the IPW, where the mean at each time point is 
close to one and the range is small. (51, 53).  In addition, time-varying covariates were 
entered into the weighting model as lagged covariates (at time t – 1), this made little 
difference to the final parameter estimates, but negatively impacted the sample size. 
Very large values of the IPW or means far from one indicated a possible violation of 
the positivity assumption or a misspecified weighting model.  One strategy to deal with 
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extreme weights was to truncate or trim the weights (53).  In our study, two percent of the 
IPW were trimmed at each end.  This resulted in weights with a mean close to one and a 
narrower range (see Figure 2).   
Results 
The distribution of wealth was highly skewed in our study (as it is in the US).  This 
was indicated by a large difference between the median and the mean.  After adjustment for 
inflation, median wealth at baseline was approximately $35,200 but mean wealth was close 
to $185,000.  At the 25
th
 percentile, wealth was about $3700 and at the 75
th
 percentile it was 
$138,700.  At baseline, 11.5% of persons had negative wealth and 5.3% reported zero wealth.  
After excluding baseline cases we were left with a sample size of 10475 in the obesity 
analysis, 10110 in the smoking analysis and 10744 in the hypertension analysis.   
Table 7 provides demographic characteristics for the study population at baseline 
prior to excluding incident cases (n=13031).  Recall that these data were not weighted by the 
PSID survey weights.  Wealth is measured at the household level, thus is the same for each 
member of the household.  The description of wealth by various individual level 
demographic characteristics may be driven by the marital status.  In an attempt to better 
understand how wealth is distributed by individual demographic characteristics, an 
alternative to Table 7 is presented in Table 8.  The total number of unique households in the 
1999-2005 PSID sample were 10,042. 
The percentage of women in the poorest wealth category was larger compared to men 
(59.2% vs 40.8%).  Among the wealthiest quintile, however, the percentage of males and 
females were similar (48.5% vs. 51.5%).  As for race, in the wealthiest quintile there were 
eight times as many white respondents compared to non-whites; while in the poorest wealth 
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category there were slightly more non-whites (55.5%) than whites (44.5%).  Education, age 
and income all showed the expected pattern.  Older, more educated and higher income 
individuals all had much more wealth than their younger, less educated and lower income 
counterparts.  For these three characteristics there was a steady and significant trend.  In 
terms of marital status, in the highest quintile of wealth there were about 21 times more 
married persons compared to the never married and 8.5 times more married compared to  
widowed, divorced or separated persons.  As far as insurance coverage reflects employment, 
another SES marker, the data revealed far fewer uninsured individuals among the wealthy; 
the percent uninsured in the least wealthy group is nine times the percent in the wealthiest 
group.  All bivariate associations presented in Table 7 had p <0.0001.   
As for the incidence of CVD risk factors, obesity and smoking declined as wealth 
increased, the incidence of obesity was almost 2.5 times higher and the incidence of smoking 
5 times higher for those in the poorest wealth category compared to those in the wealthiest.    
Hypertension generally increased with wealth.  The increase in the incidence of hypertension 
reflects the increase in hypertension that occurs with age. 
Figure 3 shows risk differences and 95% CI for the effect of wealth on obesity, 
smoking and hypertension.  Risk difference results are expressed as the number of excess 
cases of the outcome attributable to low wealth relative to wealth quintile five from 1999 to 
2005 per 1000 persons.  Figure 3 is presented in tabular form in Table 10.  The model for 
obesity produced estimates with the highest magnitude compared to the other two outcomes.  
After adjusting for baseline and time-varying confounders, the number of excess cases of 
obesity were 22 (CI: 13, 31) for the less than or equal to zero wealth group, 25 (CI: 15, 35) 
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for wealth quintile one, 14 (CI: 6, 21) for quintile two, 14 (CI: 7, 21) for quintile three and 
11(CI: 4, 17) for quintile four.   
The estimates from the smoking model had the best precision compared to estimates 
from the other two models.  The number of excess smokers was 10 (CI: 5, 16) for those in 
the less than zero wealth group, six (CI: 1,11) for the first quintile, five (CI: 0.2, 9) for the 
second quintile, four (CI: -0.5, 8) for the third quintile and three (CI: -1, 7) for the highest 
wealth group, the fourth quintile.  Compared to the other models the hypertension model 
revealed a similar (and smaller) number of excess cases regardless of wealth quintile.  The 
number of excess hypertensives were four (CI: -4, 12) for the least wealthy group, six for the 
first and second wealth quintiles (CI: -2, 14 and -1, 14 respectively), four for the third and 
fourth quintile (CI: -2, 11 and -2, 10 respectively)   
Risk ratios and 95% confidence intervals (CI) for the effect of wealth on the three 
CVD risk factors are shown in Table 9.  In the fully adjusted model, the risk of becoming 
obese was inversely related to wealth; as wealth increased the risk of obesity declined.   
Those with less than or equal to zero wealth and those with little wealth (quintile one) had a 
similar and significantly higher risk of obesity relative to the wealthiest group (quintile five), 
1.80 (CI: 1.43, 2.26) and 1.89 (CI: 1.49, 2.40) respectively.  Those in quintiles two and three 
had about a 51% (CI: 1.21, 1.88 and 1.23, 1.86 respectively) increased risk and those in 
quintile four a 40% (CI: 1.14, 1.71) increased risk of becoming obese compared to the 
wealthiest group.  The confidence limit ratios suggested these estimates were relatively 
precise compared to estimates from other models.   
The smoking model suggested a stronger magnitude of effect for the poorest wealth 
group.  The least wealthy had the highest risk of becoming smokers (2.10, CI: 1.41, 3.12).  
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Those in low wealth quintiles one and two had an increased risk of becoming smokers, with 
RR of 1.61 (CI: 1.07, 2.44) and 1.50 (CI: 1.01, 2.21) respectively.  The risk ratio for those in 
quintiles three was 1.39 (CI: 0.95, 2.04) and the lowest risk was among quintile four (1.30 
CI: 0.91, 1.87).   
The effect estimates for hypertension were more precise but of a smaller magnitude 
than the estimates from the other two outcomes.  Among the least wealthy the model 
suggested that the risk of hypertension was 10% (CI: 0.90, 1.35) higher compared to the 
wealthiest quintile.  Those in quintile one and two had about a 16% (CI for quintile one: 0.95, 
1.42 and CI for quintile two: 0.97, 1.41) increased risk of developing hypertension relative to 
the wealthiest group, while those in quintiles three and four had a 11% increased risk of 
hypertension (CI: 0.93, 1.33 and 0.95, 1.29 respectively).   
In addition, models were stratified by race and sex.  Results are not shown here, but 
are available from the authors.  For obesity, estimates for whites and women were of the 
largest magnitude while those for men were moderate and blacks showed small effects.  In 
the smoking models, women showed the strongest effects, followed by whites, males and 
finally blacks. And for hypertension, females and blacks had moderate sized effects while 
men and whites had many estimates close to null.  We also attempted to stratify by age, but 
we did not have sufficient power to use a meaningful cutoff, specifically looking at the 
retired versus the working age population.  
  In order to assess the impact of time-varying confounding we compared results from 
the MSM to traditional models controlling for time-varying confounders.  Traditional 
binomial models were similar in magnitude and direction to binomial MSM (see 
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supplemental table 1).  For each estimate the confidence intervals for the traditional estimate 
overlapped with that of its MSM counterpart.   
Discussion 
This study found a strong association between wealth and obesity incidence, a 
moderate association between wealth and smoking initiation and a weak association between 
wealth and hypertension incidence.  This was true on both the absolute and relative scales, 
where both the risk ratios and risk differences revealed similar overall patterns. Given the 
importance of cardiovascular disease to the US population, a closer examination of these 
CVD risk factors was warranted.   
Other studies that examined CVD risk factors and wealth reported similar findings.  
Several studies on obesity found a negative association with wealth, specifically among 
women and whites (7, 20, 34, 35).  A German study which compared those with excess debt 
to those without debt found those in debt to have higher odds of obesity (23).  A cross-
sectional study found no association between obesity and wealth; however wealth was 
crudely measured (24).  It should be noted that several of these studies were interested in the 
equally important question of whether poor health results in a reduction of wealth, by using 
wealth as the outcome and BMI as the main exposure of interest (20, 34, 35).  The studies by 
Zagorsky conducted longitudinal analyses thus implying that obesity causes a reduction in 
wealth (34, 35).   
The literature on smoking and wealth consisted mostly of cross-sectional studies of 
European or Australian populations (22, 26, 28) with one study of a US population (16).  All 
the cross sectional studies consistently found that the least wealthy had a higher prevalence 
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of smoking (16, 22, 26, 28).  One longitudinal study interested in reverse causality found that 
smokers had several thousand dollars less wealth compared to non-smokers (33).   
Several cross-sectional studies that looked at hypertension and wealth found stronger 
more significant inverse associations compared to our study (7, 19, 21, 27), while another 
found very similar results to ours (25).  Similarly, a longitudinal analysis of an elderly 
population in the US showed no causal link between low wealth and increased incidence of 
hypertension (36).  It should also be noted that studies using other measures of SES such as 
income and education have also found a weak but positive association with hypertension (65, 
66). 
Our study had limitations.  First, the use of self-reported data for some of the 
outcomes was not ideal.  Specifically self-reported height and weight is known to 
underestimate the true prevalence of obesity, especially among overweight women (67).  
Concerns of misclassification bias arise when classification of the outcome depends on the 
exposure.  The less wealthy were more likely to be overweight than the wealthy, and thus 
were more likely to misreport their weight leading to the potential for differential 
misclassification.  Because the less wealthy were more likely to be misclassified in their 
obesity status, our data showed fewer obese cases among the poor.  Thus the expected 
direction of the misclassification for the obesity-wealth relationship in our study was towards 
the null.   
Hypertension was most likely underreported among younger respondents who have 
yet to be diagnosed with hypertension, but accurately reported among older individuals who 
were involved in the ongoing management of the condition (68).  Several studies have found 
that women, older and more educated individuals have less misclassification for self-reported 
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hypertension than other groups (68-71).  Given the relationship between wealth, age, 
education and health insurance status (the least wealthy tend to be younger, less educated and 
uninsured) we may have differential misclassification of hypertension.  In light of this 
misclassification bias, our data would reveal fewer hypertensives among the less wealthy, 
thus potentially explaining the attenuated results we see for this outcome.          
Misclassification of smoking status is less of a problem than for obesity or 
hypertension.  In general researchers believe that self-reports are good indicators of actual 
smoking status (72-74) because they allow us to understand the duration and severity of 
smoking, which biological markers (such as cotinine) do not.   
In order to reduce measurement error around wealth, we also attempted additional 
sensitivity analysis adjusting for household size; there was little difference in the final 
parameter estimates comparing models that did and did not adjust for this covariate.    
The exclusion of baseline cases from the analysis raises questions about selection 
bias, another potential source of bias in our study.  Those with preexisting hypertension are 
more likely to be older and of lower SES.  By excluding them, the effect estimate will likely 
be biased downward.  Similarly for obesity, the exclusion of baseline cases excludes more 
low SES individuals which may result in underestimates of the effect.  That is, a sample of 
healthier, wealthier individuals will create an underestimate of the effect estimate for obesity 
and hypertension (75).    
With smoking however, the picture was more complex because smoking status was a 
composite of a few different outcomes, each with the probability of being affected by wealth 
differentially.   We conducted a sensitivity analysis for smoking where three separate 
outcomes were created for three separate subpopulations (see Table 11).  Among the non-
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smokers, we looked at the probability of smoking initiation.  Among the current smokers we 
looked at the probability of quitting and among the former smokers, we looked at the 
probability of resuming smoking.  Each of these outcomes was fit using a logistic MSM 
(because outcomes were rare).  Results from these models all went in the expected direction.  
Although the number of persons who initiated smoking was small, there was an elevated 
odds of smoking initiation among the least wealthy individuals, which declined as wealth 
increased.  The smoking cessation model showed that the least wealthy were less likely to 
quit smoking, while the wealthier quintiles were more likely to do so.  Lastly, in the smoking 
resumption model, the least wealthy were more likely to resume smoking while the wealthier 
quintiles were more likely to remain non-smokers.  The results of these models provided 
some assurance that selection bias was not severely affecting the estimates in the overall 
smoking model.  It should be noted that in addition to modeling incidence, we also modeled 
prevalence for each of the outcomes.  Results were similar, however, incidence models 
produces estimates of larger magnitude. 
There were several strengths to our study.  First, by using data from the PSID, we 
were assured that wealth was measured in a rigorous and comprehensive fashion (61).  As 
discussed earlier many epidemiologic studies measured wealth poorly, thus the estimates 
based on these studies were fraught with measurement error.  In addition, the longitudinal 
nature of the PSID allowed us to explore the question of wealth and health over a 6 year 
period.  Most studies of wealth and health to date have used cross sectional data.  A related 
advantage was our use of marginal structural models as the analytic technique to answer the 
study question.  After satisfying several important assumptions, such as the absence of 
unmeasured confounding, MSM can have a causal interpretation even in the presence of 
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time-varying confounding.  Although some of the assumptions of MSM are difficult to meet, 
we believe this study produced improved estimates relative to past studies (76).  Ideally a 
randomized controlled trial which randomly assigns wealth to each individual at baseline and 
waits for the development of one of the CVD risk factors would yield an estimate with a 
causal interpretation.  Since wealth is not easily randomizable, the consistency assumption is 
suspect; therefore, the true causal estimates of the relationship between wealth and health 
may not equal the estimates presented in our study, regardless of our improved methodology. 
As noted earlier, the results we obtained from MSM were similar to those from 
traditional models (see Table 17 in the appendix).  This indicates that there was not a 
substantial amount of time-varying confounding in our study.  We hypothesized that income 
would be the strongest time-varying confounder.  However, given our study’s short time 
interval, it is likely that income trajectories remained relatively stable during this period; thus 
it is understandable that income was not a strong time-varying confounder in these data.      
There are many potential mechanisms through which low wealth results in poor 
health outcomes.  Poor physical and social environments can encourage health damaging 
exposures (77).  For example, the lack of economic resources associated with having little 
wealth may limit an individual’s access to health care, quality housing and nutritious foods 
among other things.  A lack of economic and social resources can also result in insufficient 
investment in “human, physical, social and health infrastructure” which may be detrimental 
to the health of populations (78).  Assuming that less wealthy individuals live in less wealthy 
communities, insufficient infrastructure may take the form of fewer or less convenient public 
transportation options, a lack of parks and unsafe streets, and more liquor and convenient 
stores.  These deficiencies can then lead to increased isolation, a more sedentary lifestyle and 
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poor diets, which directly result in higher rates of smoking and obesity among less wealthy 
individuals (79, 80).  Other research has found that low SES individuals may have less social 
support, higher job strain and less job control.  All these factors have been associated with 
higher rates of smoking and obesity (81).   
Chronic stress may underlie many of these health damaging exposures (77).  Since 
wealth is a stockpile of financial resources a lack of wealth (which translates into the absence 
of a safety net) is ostensibly a cause for long-term financial stress.  It has been hypothesized 
that chronic stress and other psychosocial factors trigger a series of biological events, through 
central nervous system activation of autonomic, neuroendocrine and immune responses (82).  
These biological pathways may be especially germane to hypertension and other 
cardiovascular functions (83).  The choice of CVD risk factors as outcomes for this study 
was further underscored in light of the potential mechanisms discussed above. 
Although wealth may be more difficult to measure than other SES variables, both its 
empirical performance and its theoretical relevance make it an important factor that should 
be considered by more health researchers.  In addition, asset building programs focusing on 
the poor and middle class have shown modest success in helping families build wealth (84).  
Thus, not only is wealth a useful empirical and theoretical construct, it is also amenable to 
policy interventions that could have long term benefits for improving the health of the poor. 
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Table 7. Unweighted demographic characteristics of study population at baseline, PSID 1999- 2005 
 
<= zero 
wealth 
Quintile 1 Quintile2  Quintile3 Quintile 4 Quintile 5 
Sex       
Male 40.8 44.2 46.7 47.3 47.1 48.5 
Female 59.2 55.9 53.4 52.8 52.9 51.5 
Race       
White 44.5 44 54.7 60 73.3 89.0 
Non-white 55.5 56 45.3 40 26.7 11.0 
Education       
Less than high school 22.7 25.3 16.5 15.0 10.2 5.7 
High school graduate 37.9 44.2 42.0 41.1 39.8 29.9 
Greater than high school 39.4 30.6 41.5 43.9 50.0 64.3 
Marital status       
Never married 42.1 32.5 20.3 11.1 7.3 3.7 
Married 37.5 44.5 62.7 72.5 76.6 85.9 
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0 
Widowed, divorced or 
separated 
20.4 23.1 17.1 16.5 16.1 10.4 
No health insurance 27.1 26.5 17.1 11.0 5.8 3.0 
Mean age in years (sd) 33.7 (12.6) 34.6 (13.4) 36.6 (12.4) 41.3 (13.7) 46.8 (14.7) 52.0 (14.0) 
Mean income in dollars (sd) 29,961 
(24,609) 
30,428 
(26,542) 
43,860 
(24,488) 
52,798 
(31,547) 
67,362 (52,717) 108,832 
(120,000) 
Median wealth in dollars 
(25%, 75%) 
-3039 (-
12,000, 0) 
3189 (1488, 
5528) 
18,288 
(12,756, 
24,981) 
50,494 
(40,448, 
62,718) 
120,866 
(95,916, 
153,076) 
396,508 
(270,008, 
730,298) 
Incidence of health 
outcomes (per 100 person 
years) 
      
Obesity 9.1 9.4 7.9 7.6 5.9 3.8 
Smoking 5.7 4.2 3.4 2.6 2.0 1.1 
Hypertension 6.5 6.8 7.0 7.3 7.9 7.4 
Results are expressed in percentages unless otherwise indicated. 
Sample size for Table 1 is 13,031. 
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All bivariate analysis had p < 0.0001.  P-values are from chi-squared test for sex, race, education, marital status, health insurance 
and from ANOVA for age, income and wealth. 
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Table 8. Descriptive characteristics at baseline by household size, PSID 1999-2005 
 
≤ 0 
wealth 
Quintile 
1 
Quintil
e 2 
Quintil
e 3 
Quintil
e 4 
Quintil
e 5 
Sex       
1 person household       
1 Male 26.6% 25.0% 18.6% 12.1% 10.2% 7.6% 
1 Female 29.7% 24.0% 16.4% 11.7% 10.8% 7.3% 
2 person household       
1M, 1F 11.4% 13.1% 16.3% 16.8% 19.3% 23.1% 
2M or 2F 42.9% 28.6% 14.3% 7.1% 7.1% 0.0% 
Race       
1 person household       
1 White 20.4% 20.6% 18.0% 13.7% 14.6% 12.7% 
1 Non-white 36.7% 28.2% 16.3% 10.1% 6.6% 2.1% 
2 person household       
2 Whites 9.0% 8.7% 13.5% 15.4% 21.6% 31.9% 
2 Non-whites 15.3% 21.6% 21.8% 20.3% 14.4% 6.5% 
2, mixed 14.1% 14.1% 17.9% 14.5% 20.7% 18.6% 
Education       
1 person household       
1 adult, less than high 
school 40.0% 30.4% 11.3% 9.2% 6.0% 3.0% 
1 adult, high school 27.5% 28.1% 17.0% 11.6% 10.0% 5.8% 
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degree 
1 adult, greater than high 25.3% 19.3% 19.2% 12.8% 13.0% 10.4% 
2 person household       
2 adults, less than high 
school  13.9% 27.8% 22.5% 16.8% 12.7% 6.3% 
2 adults, high school 
degree 11.7% 14.5% 18.7% 18.6% 20.0% 16.5% 
2 adults, greater than high 
school 10.3% 5.9% 13.0% 14.6% 19.6% 36.5% 
2 adults, mixed 10.7% 14.7% 16.1% 17.6% 19.9% 21.0% 
Marital status       
1 person household       
1 adult married, but 
spouse is absent 20.2% 17.5% 21.0% 15.9% 14.0% 11.5% 
1 adult, 
widowed/divorced/sep 20.7% 21.4% 17.0% 15.2% 15.2% 10.6% 
1 adult, never married 37.4% 29.1% 16.3% 7.9% 5.7% 3.6% 
2 person household       
2 adults, married 9.4% 10.9% 16.1% 17.5% 20.5% 25.6% 
2 adults, not married 23.2% 25.5% 17.5% 12.9% 12.1% 8.8% 
Wealth (median $)       
1 person -1,500 
            
2,888  
        
18,339  
        
52,620  
      
123,275  
     
381,626  
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2 people -15,847 
            
3,842  
        
19,348  
        
52,181  
      
126,701  
     
818,168  
Income (mean $)       
1 person 
          
23,022  
         
24,733  
        
39,219  
        
44,573  
        
53,550  
       
58,000  
2 people 
          
38,819  
         
37,003  
        
46,633  
        
56,203  
        
71,421  
     
113,046  
Age (mean)       
1 person 33 34 37 43 49 52 
2 people* 35 35 38 42 48 54 
*age of oldest person       
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Figure 3. Cardiovascular disease risk factors by wealth quintile, risk differences and 95% confidence intervals, PSID 1999-2005 
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Table 9. Risk ratios and 95% confidence intervals of the association between wealth and obesity incidence, smoking initiation and 
hypertension incidence, PSID 1999 - 2005 
 Obesity   Smoking   Hypertension   
 risk 
ratio 
Lower 
95% CI 
Upper 
95% CI 
risk 
ratio 
Lower 
95% CI 
Upper 
95% CI 
risk ratio Lower 
95% CI 
Upper 
95% CI 
≤  zero 
wealth 
1.80 1.43  2.26 2.10 1.41  3.12 1.10 0.90  1.35 
Quintile 1 1.89 1.49  2.40 1.61 1.07  2.44 1.16 0.95  1.42 
Quintile 2 1.51 1.21 1.88 1.50 1.01 2.21 1.17 0.97 1.41 
Quintile 3 1.52 1.23 1.86 1.39 0.95  2.04 1.11 0.93 1.33 
Quintile 4 1.40 1.14 1.71 1.30 0.91 1.87 1.11 0.95 1.29 
Quintile 5 Referent   Referent   Referent   
          
*All models adjusted for baseline covariates (sex, age, race, education, region, general health status, marital status, income and 
insurance status) and time-varying covariates (income, marital status and insurance status) through the IPW. 
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Table 10. Risk differences and 95% confidence intervals of the association between wealth and obesity incidence, smoking 
initiation and hypertension incidence expressed as cases per 1000 persons over 6 year follow up, PSID 1999 - 2005 
 Obesity   Smoking   Hypertension   
 risk 
difference 
Lower 
95% CI 
Upper 
95% CI 
risk 
difference 
Lower 
95% CI 
Upper 
95% CI 
risk 
difference 
Lower 
95% CI 
Upper 
95% CI 
≤  zero 
wealth 
22 13 31 10 5 16 4 -4 12 
Quintile 1 25 15 35 6 1 11 6 -2 14 
Quintile 2 14 6 21 5 0.2 9 6 -1 14 
Quintile 3 14 7 21 4 -0.5 8 4 -2 11 
Quintile 4 11 4 17 3 -1 7 4 -2 10 
Quintile 5 Referent   Referent   Referent   
          
*All models adjusted for baseline covariates (sex, age, race, education, region, general health status, marital status, income and 
insurance status) and time-varying covariates (income, marital status and insurance status) through the IPW. 
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Table 11. Risk ratios and 95% confidence intervals of the association between wealth and the initiation, initial cessation and 
resumption of smoking, PSID 1999 – 2005 
 Initiation  Cessation  Resumption  
 risk ratio 95% Confidence 
Interval 
risk ratio 95% Confidence 
Interval 
risk ratio 95% Confidence 
Interval 
≤  zero 
wealth 
2.17 0.84, 5.60 0.78 0.57, 1.06 1.88 1.17, 3.02 
Quintile 1 1.79 0.67, 4.82 0.82 0.60, 1.11 1.39 0.84, 2.30 
Quintile 2 1.46 0.58, 3.69 0.80 0.60, 1.08 1.41 0.89, 2.25 
Quintile 3 1.31 0.52, 3.28 0.91 0.69, 1.20 1.41 0.89, 2.22 
Quintile 4 1.22 0.51, 2.89 1.08 0.82, 1.41 1.16 0.75, 1.77 
Quintile 5 Referent  Referent  Referent  
*All models adjusted for baseline covariates (sex, age, race, education, region, general health status, marital status, income and 
insurance status) and time-varying covariates (income, marital status and insurance status) through the IPW. 
 
   
 
Chapter 6 
Long-term effects of wealth on mortality and health status 
Abstract 
Background: The use of wealth as a measure of socioeconomic status remains uncommon in 
epidemiological studies. When used, wealth is often measured crudely and at a single point in 
time.  
Objective: This study explores the relationship between wealth and 2 health outcomes, 
mortality and self-reported general health status (GHS) in a US population.  
Methods: To improve upon the existing literature, this study uses a detailed and validated 
measure of wealth in a longitudinal setting. Data for this study are from 7 waves of the Panel 
Survey on Income Dynamics collected between 1984 and 2005. Inverse probability weights 
were employed to control for time-varying confounding and to estimate both relative and 
absolute measures of effect.  Binomial marginal structural models (MSM) were used to 
analyze general health status and logistic MSMs were used to investigate the wealth-
mortality association.  Wealth was defined as inflation-adjusted net worth and specified as a 
6 category variable: 1 category for those with less than or equal to 0 wealth and quintiles of 
positive wealth.  
Results: In the fully adjusted model, the incidence of poor health status was inversely related 
to wealth. There was a 17% to 54% higher risk of falling into poor health and 6 to 22 excess 
cases of poor health (per 1000 persons) among the less wealthy relative to the wealthiest 
quintile.  Stratified models revealed that less wealthy men, women and whites also had
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higher risk of poor health status relative to their wealthy counterparts.  The overall wealth-
mortality association revealed an 83% increased risk and 5 excess cases of death (per 1000) 
among the least wealthy compared to the wealthiest.  Less wealthy women had the largest 
relative mortality risks (risk ratios between 2.29 and 1.37) and men with less than or equal to 
0 wealth had the largest absolute mortality risk (7 excess cases) compared to the wealthiest 
quintile.   
Conclusion: There is a strong inverse association between wealth and incidence of poor 
GHS and between wealth and mortality.   
 
   
71 
 
Introduction 
The goal of this study was to explore the relationship between wealth, a measure of 
socioeconomic status (SES) not commonly used in the health literature, and 2 health 
outcomes: (1) self-reported general health status (GHS) and (2) mortality.  Wealth is defined 
as the stockpile of resources amassed over the lifetime (4, 5).  Income is defined as the flow 
of resources into the household and consumption as the flow of resources out of the 
household.  Savings is the difference between income and consumption and is transformed 
into wealth (through the purchase of cars, houses or stocks and bonds or the reduction of 
debt).   Thus, by definition, income and wealth are related but separate constructs.   
Wealth is a more stable measure of SES (it is less subject to fluctuation than income) 
and it may better represent the true social hierarchy as it encompasses both economic 
circumstances and prestige or status (3).  In addition, wealth may better measure SES during 
certain times in the life course (when income is lost due to unemployment or illness) and for 
certain populations (the elderly) (8).  However, given the many components of wealth it is 
more difficult to measure than other measures of SES, thus it is used less often in health 
literature.  Using data from the Panel Survey on Income Dynamics (PSID), a study with 
detailed wealth measurement and extensive follow-up, we evaluated the wealth-health 
relationship in a non-elderly adult US population.   
Methods 
PSID, a longitudinal study of the US population, began in 1968 and continues today.    
The use of survey weights when analyzing PSID data produces nationally representative 
estimates.  However, survey weights were not used in the current analysis.  Because we are 
interested in an etiologic hypothesis rather than population representative prevalence 
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estimates, we treat the PSID population as a cohort rather than a sample.  Causal parameters 
estimated in our models therefore have in-sample interpretations and are not applicable to the 
broader US population.  Much has been written about the design and content of the PSID 
elsewhere (62).  Data for this study came from 7 waves of the PSID: 1984, 1989, 1994, 1999, 
2001, 2003 and 2005.  Health questions were asked only of the head of household and his/her 
partner.   
Measures 
The health outcomes examined in this study were GHS and mortality.  The GHS 
variable was derived from the standard question “Would you say your health in general is 
excellent, very good, good, fair or poor?”  In keeping with several other papers on wealth and 
health, it was dichotomized as excellent, very good and good versus fair and poor.  At the 
onset of the study PSID relied on non-response, returned postal materials and information 
from surviving family members to identify deaths.  PSID subsequently verified most deaths 
using the National Death Index.  The mortality status of respondents who were lost to follow-
up, however, remained unknown (85).  The maximum follow-up time for mortality was 21 
years (from 1984 to 2005).     
Family wealth was defined as total net worth, which includes the value of one’s 
primary home, farm or business assets, checking or savings accounts, vehicles, second 
homes, stocks and bonds.  Debt was subtracted from these assets.  This approach to 
measuring wealth included all major components and resulted in estimates that were 
consistent with other studies (61).  Wealth was adjusted for inflation using the 2001 
consumer price index and specified as a 6 category variable, where category 1 included all 
those that had negative or 0 wealth and categories 2 through 6 were quintiles of positive 
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wealth.  In the final models, wealth was specified as 5 indicator terms (i.e. dummy variables) 
to avoid making any assumptions about linearity.  The referent group was the highest wealth 
quintile.  For stratified models, wealth categories were redefined for only the population of 
interest (e.g. the model for women defined wealth categories only among women).    
Other covariates included in models for both outcomes were income, marital status, 
region of residence, education, age, race and sex.  Income was specified as a continuous 
poverty-to-income ratio using the annual poverty thresholds from the Census Bureau and 
accounting for number of people in the household.  Marital status was categorized as married 
(the referent group), never married or divorced, separated or widowed, and specified as 
indicator terms.  The 3 indicator variables for region classified state of residence as northeast, 
midwest or south; west was the referent group.  Education was specified as 2 indicator 
variables, (< high school and high school degree) and greater than high school was the 
referent group.  Age was specified as a continuous centered variable for both outcomes.  An 
indicator variable for race included all non-white participants, which in PSID consists mostly 
of African-Americans and the referent group was non-Hispanic white.  The mortality model 
also included dichotomized GHS as an additional covariate.   
Statistical analysis 
Adjusted associations were estimated using both absolute and relative measures of 
effect for the total population and for men, women, whites and non-whites separately.  For 
GHS, a binomial marginal structural model (MSM) yielded adjusted risk ratios directly.  For 
mortality, a cumulative incidence model, fitted with a logistic MSM, was used to ascertain 
risk of death.  Risk differences were calculated by taking the differences between predicted 
probabilities estimated from logistic regression models.  The delta method was used to 
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estimate the variances for risk differences (63) via the marginal effects post-estimation 
procedures available in Stata version 10 (59).   Risk differences were calculated holding all 
covariates at their mean values, which corresponds to standardization of the effect estimates 
to the covariate distribution in the total study population (86).   
The major time-varying confounders of mortality were income, marital status and 
GHS; for GHS they were income and marital status.  The main exposure, wealth, was also 
time-varying.  Wealth categories were based on the distribution of wealth for each specific 
model; for example in the model for men, wealth quintiles reflected the distribution of wealth 
only among men.  Sex, race, age, education and region were ascertained at baseline and 
treated as time-invariant.  Baseline values for all time-varying confounders were also 
included in the final MSM.  In GHS models, starting values from Poisson regression were 
used if the binomial model did not converge (64).    
In households where both the head of household and partner were present, there was 
clustering by household.  Furthermore, there was 1 observation per time point per person, 
resulting in additional clustering by individual.  We adjusted the variances for clustering at 
the highest level of aggregation, which produced valid estimates by accounting for both 
sources of dependence (55, 56).  Thus a family id variable was used to obtain robust standard 
errors. 
For the GHS analysis, individuals who reported poor GHS at baseline were excluded.  
Participants were allowed to enter the study at any point in time (between 1984 and 2003) as 
long as they participated for more than 1 year of data collection.   
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Calculating inverse probability weights 
Inverse probability weights (IPW) are a key feature of MSM.  Through the use of 
these weights time-varying confounding is controlled (51, 52).  IPW were estimated from 
predicted probabilities obtained from logistic and multinomial models.  Logistic models were 
used to obtain censoring weights, where the outcome of interest was whether the individual 
was lost to follow-up at that time point.  Multinomial (i.e. proportional odds) models were 
used to obtain treatment weights, where the 6 category wealth variable was the outcome.  
Multiplying the treatment and censoring weights resulted in the final IPW.  In the weighting 
model, continuous variables, income and age (centered on the mean), were specified flexibly; 
age as a linear term, squared term and 2 quadratic splines and income as linear, squared and 
cubic terms.  The numerator of the weight contains all baseline covariates while the 
denominator contains baseline and time-varying confounders.  Several weighting models 
were tested and the best one was chosen depending on the distribution of the IPW.  Desirable 
properties for the IPW are a mean close to 1 and a small range (51, 53).   
Very large values of the IPW or means far from 1 indicated a possible violation of the 
positivity assumption or a misspecified weighting model.  One strategy used to deal with 
extreme weights is to truncate or trim the weights (53).  In our study, 2 percent of the IPW 
were trimmed at each end.  This resulted in weights with a mean close to 1 and a much 
narrower range of values (see Figure 2).   
Results 
For the mortality analysis the sample size was 26,614.  After excluding 2,419 
participants with fair or poor health status at baseline, the sample size for the GHS analysis 
was 15,745.  Overall there were 2,162 deaths (8.12%) and the prevalence of poor or fair 
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health status was 13.4% at baseline.  Table 12. Unweighted demographic characteristics of 
the study population at baseline, PSID 1984 – 2005Table 12 provides demographic 
characteristics by quintiles of wealth for the study population at baseline prior to excluding 
incident GHS cases (n=18,164).  All members of the household share the same level of 
wealth, but some demographic characteristics reflect individual level attributes.   
After adjustment for inflation, median wealth at baseline was approximately $20,500 
but mean wealth was close to $109,100; indicating the highly skewed nature of household 
wealth.  The percentage in the poorest wealth category was higher for women compared to 
men (about 60% vs 40%).  As wealth increased, however, the male/female gap declined and 
was nearly eliminated at the highest quintile of wealth.  In the wealthiest quintile there were 
almost 7 times as many white respondents compared to non-whites; while in the poorest 
wealth category the gap was reduced to 1.5 times as many non-white respondents.  
Education, age and income all showed the expected pattern.  Older, more educated and 
higher income individuals all had much more wealth than their younger, less educated and 
lower income counterparts.  For these 3 characteristics there was a steady trend (p for trend: 
<0.0001).  Marital status is a known predictor of wealth; in the highest quintile of wealth 
there were about 19 times more married persons compared to the never married and 10 times 
more married compared to widowed, divorced or separated persons.  The percent of persons 
reporting poor GHS declined as wealth increased, but the percentage of deaths increased with 
greater wealth.  In this crude analysis, the increasing deaths were likely a result of increasing 
age.  All bivariate associations presented in Table 12 were significant at the 0.0001 level. 
There was a strong association between GHS and wealth on both the relative and 
absolute scales.  In the fully adjusted models, the risk of developing poor GHS was inversely 
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related to wealth; as wealth increased the risk of poor GHS declined.   In the risk ratio model 
(depicted in Figure 4), those with less than or equal to 0 wealth had a significantly higher risk 
of poor health relative to the wealthiest group (quintile 5), 1.54 (95% confidence interval 
(CI): 1.27, 1.88) and those in quintile 1 had a 41% (CI: 1.18, 1.69) increased risk of poor 
health.  Those in quintiles 2 through 4 also had a significantly elevated risk of poor health, 
but of a lower magnitude than the lower wealth groups (1.21, 1.25 and 1.17 respectively).   
Figure 5 shows risk differences expressed as the number of excess cases of poor 
perceived health attributable to having low wealth (≤ 0 wealth) instead of high wealth 
(quintile 5) from 1984 to 2005 per 1,000 persons.  After adjusting for covariates, among 
those with less than or equal to 0 wealth, there were 22 (CI: 13, 32) excess cases between 
1984 and 2005.  In quintile 1, there were 16 (CI: 8, 24) and in quintile 2 there were 8 (CI: 1, 
16) excess cases.  Quintiles 3 and 4 had 9 and 6 excess cases of poor health, respectively.  
Tabular data for Figure 4 and Figure 5 is presented in Table 15.  Stratified models for GHS 
revealed a similar pattern (Table 13 and Table 14).  Among men and whites the least wealthy 
had the highest risk of poor health on the risk ratio and risk difference scales.  Among 
women those with less than or equal to 0 wealth had a similarly elevated risk of poor health 
as those in quintile 1 (1.56 and 1.62 respectively).  In general, for men, women and whites 
the risk of poor health declined as wealth increased.  The binomial model for non-whites, 
however, showed a near null association for the poorest wealth quintiles and a protective 
effect for the wealthier quintiles.  The results for non-whites on the absolute scale revealed 
highly imprecise estimates compared to the other stratified models. 
In the mortality analysis, both the absolute and relative models revealed an increased 
risk of death among less wealthy groups (Figure 6, Figure 7 and Table 16).  In the total 
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population, those with less than or equal to 0 wealth had an 83% higher risk of death 
compared to the wealthiest group (CI: 1.44, 2.31).  Low wealth quintiles 1 and 2 had a 
similarly elevated risk of death (40% and 41% respectively), while the risk of death fell for 
those in quintiles 3 and 4 (risk ratio 1.35 and 1.25 respectively).  On the absolute scale, this 
represents an excess of 5 deaths among the least wealthy, an excess of 2 deaths among 
quintiles 1, 3 and 4 and an excess of 3 deaths among those in quintile 2. 
In the stratified mortality analysis, the relative measures for women revealed the strongest 
magnitude compared to the other subgroups (Table 13).  Women in the least wealthy group 
had an increased risk of 129% relative to the wealthiest women, while women in quintile 4 
still had a 37% increased risk of death.  The models for men, whites and blacks revealed an 
increased risk of death among the lowest wealth quintile (1.61, 1.87 and 1.69 respectively), 
with a declining risk among higher wealth quintiles.  There was an excess of 7 deaths among 
men, 6 among blacks, 5 among women and 4 among whites in the least wealthy group (CI: 
2,11; 2,10; 2,7 and 1,7 respectively).  Several of the higher wealth quintiles in the models for 
men and blacks contained the null value (Table 14). 
Discussion 
Our study found a strong inverse association between wealth and GHS and wealth 
and mortality.  Stratified GHS models revealed a similarly strong association for men, 
women and whites, while stratified mortality models suggested strong relative effects among 
women and whites.   
Several previous studies on wealth and mortality have found similar results.    Several 
US studies that used a well-measured wealth variable found a positive association between 
wealth and mortality (10, 43-47).  There are, however, 2 US studies that did not find an 
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association between wealth and mortality.  The study by Feinglass et al concluded the lack of 
association between wealth and mortality after 10 years of follow-up was a result of 
controlling for baseline health status, an important mediator in the wealth-mortality 
association (48).  In addition, an econometric study tested specifically for the “absence of 
causal links from wealth to mortality” and found evidence to support the claim (36).   
A potential source of bias in our mortality analysis was the relatively high level of 
attrition in PSID.  Respondents who were lost to follow up were included in the analysis and 
censored at their last time point; however, their mortality status remained unknown.  If there 
was differential mortality between the censored and the uncensored respondents, (censored 
individuals had higher mortality rates and were less wealthy) we would observe bias towards 
the null.  That is our results may be underestimating the real mortality risk.  PSID conducted 
an internal examination of the impact of attrition on mortality and found that the mortality 
status of 11% of a sample of persons lost to follow-up could not be determined and about 3% 
were actually deceased (85).   
Initial mortality models included total time of study participation as an additional 
covariate.  We found that this time variable was negatively associated with death; that is the 
longer one was in the study the less likely s/he was to die.  This selection bias towards 
healthy individuals was sufficiently strong as to skew the results in the opposite direction, 
thus we excluded it from future analysis. 
Our findings for GHS were also similar to that of several other studies (7, 16, 29-32, 
38-41).  Most studies to date, however, used cross-sectional data (7, 11, 16, 29-32).  Two 
longitudinal studies found results similar to ours; low wealth was associated with poor health 
status (40, 41).  Several econometric analyses of the wealth – health question, however, 
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found little support for the conclusion that low levels of wealth cause poor health (36, 38, 39, 
42).  In fact their results suggested the opposite, poor health causes declines in wealth (36, 
38, 39).  These studies, however, were interested in the short term effects of wealth on 
perceived health status (36, 38, 39, 42).  A serious change in health status is likely to have an 
immediate effect on a household’s financial well being.  This is evidenced by the well known 
statistic that in 2007 over 60% of personal bankruptcies were caused by illness of a family 
member (87).  Thus in the short term whether poor health causes reductions in family wealth 
is a critical question, however, this short term approach could explain the null results of the 
wealth to health hypothesis found in these studies (36, 42, 88). 
By using longitudinal data with an extensive follow up (about 21 years) and 
excluding baseline cases of poor health status, the estimates presented in our study provide 
firm evidence for the hypothesis that low levels of wealth cause poor perceived health status 
in the long term.  In light of the cumulative disadvantage hypothesis (which posits that 
inequalities in SES worsen over the life-course) understanding the long term effects of SES 
on health is important (89, 90).  Other studies with long follow up times further corroborated 
our results (41).   
Limitations of our study included the potential for selection bias caused by the 
exclusion of baseline cases in the GHS analysis.  Those in poor health were more likely to be 
older and less wealthy, causing the effect estimates to be biased downwards.  Thus, our 
results may have underestimated the true effect (75).  As previously discussed, another 
limitation to our study was the misclassification of mortality for those lost to follow up.  
With any longitudinal study of considerable follow-up, the introduction of bias is 
unavoidable in the face of attrition.    
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We believed that adjusting for income was necessary in order to understand the true 
effect of wealth on these health outcomes.  However, the close conceptual relationship 
between income and wealth may cause some concern about this decision.  Empirically, there 
is a low correlation between income and wealth in the PSID, which has been noted in other 
studies as well (5).  GHS models that did not include either baseline or time varying income 
revealed risk ratios of a substantially larger magnitude.  As expected, income is attenuating 
the effect of wealth on GHS, thus at the very least our results provide conservative estimates 
of the wealth-health relationship. 
There were several strengths to our study.  First, the wealth data in PSID were 
measured in a rigorous and comprehensive fashion (61).  Many epidemiologic studies 
measured wealth crudely, resulting in invalid estimates.  Other researchers have been 
working on devising a novel set of questions to measure wealth effectively yet more 
succinctly specifically for health research looking at US populations (13).  In addition, the 
longitudinal nature of the data (21 years of follow up) allowed us to explore the question of 
wealth and health from a life course perspective.  Many studies of wealth and health to date 
have used cross sectional data and several that approach the question longitudinally have 
relatively short follow up times.  A related advantage was our use of MSM as the analytic 
technique to answer the study question.  After satisfying several important assumptions, 
MSM can have a causal interpretation even in the presence of time-varying confounding.  
The use of this analytic technique to obtain a “causal” estimate presumes a manipulable 
exposure and a realistic intervention regime (91).  Since wealth distributions are partly 
determined by government policies such as tax laws, this assumption of manipulability is not 
wholly unreasonable.   
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Several mechanisms have been proposed for how low SES impacts health outcomes. 
The less wealthy may be more subject to poor physical and social environments which can 
encourage health damaging exposures (77).  In addition, the lack of a safety net associated 
with having little or no wealth can cause chronic stress among the poor.  It has been 
hypothesized that chronic stress and other psychosocial factors trigger a series of biological 
events, through central nervous system activation of autonomic, neuroendocrine and immune 
responses resulting in poor health (82).   
Wealth has been underused in health research.  In US populations, it has several 
advantages compared to other more commonly used measures of SES.  Eliminating health 
disparities in SES will require a more complete understanding of the economic and social 
resources available to poor families; one that can hopefully be gained through the increase 
use of wealth in health research. 
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Table 12. Unweighted demographic characteristics of the study population at baseline, PSID 
1984 – 2005 
 <= 0 
wealth 
Quintile 
1 
Quintile2  Quintile3 Quintile 
4 
Quintile 5 
Sex       
Male 40.1 45.9 47.7 47.4 47.8 48.3 
Female 59.9 54.1 52.3 52.6 52.2 51.8 
Race       
White 40.0 48.2 59.2 65.1 75.9 87.3 
Non-white 60.0 51.8 40.8 34.9 24.1 12.7 
Education       
Less than 
high school 
30.3 27.9 19.2 21.9 16.2 12.4 
High 
school 
graduate 
36. 5 44.6 40.9 40.0 39.6 37.2 
Greater 
than high 
school 
33.3 27.5 40.0 38.1 44.3 50.4 
Marital 
status 
      
Never 
married 
43.3 31.5 20.6 11.7 7.6 4.6 
Married 39.2 51.8 67.6 76.5 80.3 86.7 
Widowed, 
divorced 
or 
17.5 16.7 11.8 11.8 10.2 8.8 
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separated 
Mean age 
in years 
(sd) 
30.7 
(11.8) 
31.0 
(12.1) 
32.6 (12.0) 36.5 
(12.9) 
41.3 
(13.8) 
47.7 (14.4) 
Mean 
income in 
dollars (sd) 
20,291 
(20,421) 
22,298 
(19,216) 
31,856 (20,271) 36,916 
(24,439) 
44,000 
(31,584) 
60,874 
(66,912) 
Median 
wealth in 
dollars 
(25%, 
75%) 
-7,517 
(-5,700, 
0) 
3,640 
(1,364, 
5,634) 
19,203 
(12,787,25,095) 
51,909 
(40,909, 
61,363) 
116,306 
(92,264, 
136,207) 
608,342 
(218,179, 
507,778) 
Prevalence 
of health 
outcomes 
      
% poor 
health 
18.9 14.1 11.3 12.1 11. 6 11.1 
% of 
deaths 
5.7 5.4 6.2 7.9 10.6 17.7 
       
Results are expressed in percentages unless otherwise indicated. 
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Figure 4. Risk ratios and 95% confidence intervals for incidence of poor health status by 
wealth quintile, PSID 1984-2005 
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Figure 5. Risk differences and 95% confidence intervals for incidence of poor health status 
by wealth quintile, PSID 1984-2005 
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Figure 6. Risk ratios and 95% confidence intervals of mortality by wealth quintile, PSID 
1984-2005 
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Figure 7. Risk differences and 95% confidence intervals of mortality by wealth quintile, 
PSID 1984-2005 
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Table 13. Risk ratios and 95% confidence intervals for the association between mortality, general health status and wealth among 
men, women, whites and non-whites, PSID 1984 - 2005 
Self-Reported General Health Status 
 Men 95% CI Women 95% CI White 95% CI Non-White 95% CI 
 ≤ 0 wealth 1.75 1.32, 2.31 1.56 1.18, 2.05 2.01 1.54, 2.62 1.02 0.80,1.31 
Quintile 1 1.41 1.08, 1.82 1.62 1.26, 2.09 1.65 1.31, 2.10 1.00 0.78, 1.28 
Quintile 2 1.29 1.01, 1.66 1.30 1.01, 1.68 1.38 1.10, 1.72 0.88 0.69, 1.12 
Quintile 3 1.19 0.95, 1.50 1.50 1.18, 1.89 1.23 0.99, 1.52 0.91 0.71, 1.16 
Quintile 4 1.14 0.92, 1.42 1.19 0.95, 1.49 1.06 0.87, 1.30 0.89 0.69, 1.13 
Quintile 5 Referent  Referent  Referent  Referent  
Mortality 
 Men 95% CI Women 95% CI White 95% CI Non-White 95% CI 
 ≤ 0 wealth 1.61 1.15, 2.25 2.29 1.60, 3.26 1.87 1.33, 2.63 1.69 1.17, 2.44 
Quintile 1 1.23 0.89, 1.71 1.79 1.27, 2.54 1.77 1.30, 2.40 1.23 0.82, 1.83 
Quintile 2 1.11 0.81, 1.53 1.93 1.37, 2.73 1.30 0.94, 1.80 1.08 0.71, 1.64 
Quintile 3 1.14 0.86, 1.51 1.84 1.32, 2.55 1.24 0.94, 1.64 1.50 1.02, 2.20 
Quintile 4 1.20 0.91, 1.58 1.37 1.02, 1.83 1.12 0.90, 1.40 1.38 0.94, 2.02 
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Quintile 5 Referent  Referent  Referent  Referent  
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Table 14. Risk difference and 95% confidence intervals for the association between mortality, general health status and wealth 
among men, women, whites and non-whites, PSID 1984 - 2005 
Self-Reported General Health Status 
 Men 95% CI Women 95% CI White 95% CI Non-White 95% CI 
 ≤ 0 wealth 29 15, 42 22 9, 34 29 17, 42 4 -13, 22 
Quintile 1 15 4, 25 23 12, 34 20 10, 29 1 -15, 18 
Quintile 2 11 1, 21 11 1, 21 11 3, 18 -7 -23, 8 
Quintile 3 7 -2, 16 18 8, 27 6 0, 13 -5 -21, 11 
Quintile 4 5 -3, 13 6 -2, 15 2 -4, 7 -7 -22, 9 
Quintile 5 Referent  Referent  Referent  Referent  
Mortality 
 Men 95% CI Women 95% CI White 95% CI Non-White 95% CI 
 ≤ 0 wealth 7 2, 11 5 2, 7 4 1, 7 6 2, 10 
Quintile 1 3 -1, 7 3 1, 5 4 1, 6 2 -2, 6 
Quintile 2 1 -2, 5 3 1, 5 1 0, 3 1 -3, 5 
Quintile 3 2 -2, 5 3 1, 5 1 0, 3 4 0, 9 
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Quintile 4 2 -1.1, 5 1 0.1, 3 1 -0.5, 2 3 -0.5, 7 
Quintile 5 Referent  Referent  Referent  Referent  
*per 1,000 persons 
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Table 15. Risk ratios, risk differences and their respective 95% confidence intervals for the 
association between general health status and wealth, PSID 1984 – 2005 
 Risk ratio 95% CI 
 
Risk 
difference* 
95% CI 
≤  0 wealth 1.54 1.27, 1.88 22 13, 32 
Quintile 1 1.41 1.18, 1.69 16 8, 24 
Quintile 2 1.21 1.01, 1.45 8 1, 16 
Quintile 3 1.25 1.06, 1.47 9 3, 16 
Quintile 4 1.17 1.00, 1.37 6 0, 13 
Quintile 5 Referent  Referent  
*per 10,000 persons 
 
Table 16. Risk ratios, risk differences and their respective 95% confidence intervals for the 
association between mortality and wealth, PSID 1984 – 2005 
 Risk ratio 95% CI 
 
Risk 
difference* 
95% CI 
≤  0 wealth 1.83 1.44, 2.31 5 3, 7 
Quintile 1 1.40 1.10, 1.77 2 1, 4 
Quintile 2 1.41 1.12, 1.77 3 1, 4 
Quintile 3 1.35 1.09, 1.67 2 1, 4 
Quintile 4 1.25 1.03, 1.51 2 0.2, 3 
Quintile 5 Referent    
*per 1000 persons
   
 
Chapter 7 
Discussion 
Summary of findings and study aims 
The aims of this dissertation were straightforward and the study questions asked were 
simple.  The first aim of this dissertation was to investigate the association between wealth 
and the incidence of 3 cardiovascular disease risk factors: smoking, hypertension and obesity 
on the absolute and relative scales in the time period 1999 - 2005.  The results for aim 1 
showed a strong association between wealth and obesity incidence, a moderate association 
between wealth and smoking initiation and a weak association between wealth and 
hypertension incidence.  This was true on both the absolute and relative scales, where both 
the risk ratios and risk differences revealed similar overall patterns.  
Aim 2 of this study was to investigate the overall, gender and race specific 
association between wealth and all-cause mortality and poor self-reported general health 
status on the absolute and relative scales in the time period 1984 - 2005.  Our study of the 
association between wealth and these 2 health outcomes found a strong inverse association 
between wealth and GHS and between wealth and mortality.  GHS models stratified by race 
and gender revealed a similarly strong association for men, women and whites, while 
stratified mortality models suggested strong relative effects among women and whites.  
Strengths 
There were several strengths to our study.  First, by using data from the PSID, we 
were assured that wealth was measured in a rigorous and comprehensive fashion (61).  As 
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discussed earlier many epidemiologic studies measured wealth poorly, thus the estimates 
based on these studies run the risk of serious measurement error (8).  Furthermore, many 
studies that use wealth as a measure of SES focus solely on elderly populations (11, 19-21, 
25, 27, 30, 36, 38, 39, 45, 48).  This study sought to understand the association between 
wealth and health in a working age population.  Our results indicate that wealth is indeed 
associated with several different health outcomes implying it may be useful as an additional 
measure of SES among non-elderly populations.  Although the wealth-health association may 
not be as strong as the income-health association, the conceptual advantages of wealth may 
outweigh empirical considerations in certain cases.  That is researchers should consider their 
study population as well as the nature of the SES-health relationship when selecting a 
measure of SES to use in future health studies.      
In addition, the longitudinal nature of the data allowed us to explore the question of 
wealth and health from a life course perspective as well as to attempt to disentangle the 
direction of the causal relationship between wealth and health.  Most previous studies of 
wealth and the health outcomes studied here have used cross sectional data (7, 7, 11, 16, 16, 
19-32), making it impossible to disentangle the direction of causality.  A related advantage 
was our use of marginal structural models as the analytic technique to answer the study 
question.  After satisfying several important assumptions, MSM can have a causal 
interpretation even in the presence of time-varying confounding.  Without overstating the 
causal nature of the association between wealth and health, we believe this study produced 
improved estimates relative to past studies (76).   
However, it should be noted that the results we obtained from MSM were similar to 
those from traditional models for the CVD risk factors and for GHS (see Table 17 and Table 
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18, in the Appendix).  This indicates that there was not a substantial amount of time-varying 
confounding in these health outcomes.  We hypothesized that income would be the strongest 
time-varying confounder.  However, given the short time interval in the CVD analysis, it is 
likely that income trajectories remained relatively stable during this period; thus it is 
understandable that income was not a strong time-varying confounder for the CVD risk 
factor.  It is well known that the strong confounders for the SES - CVD association are 
actually time-invariant confounders such as age, race and sex; this was confirmed in our 
study.  
In the mortality analysis, however, there was a considerable amount of time-varying 
confounding (see Table 18 in the Appendix).  In light of the longer follow up in the mortality 
analysis, more time-varying confounding was anticipated.  Furthermore, the differences 
between traditional and MSMs could reflect the difference in the nature of the mortality 
outcome compared to the other self-reported ones.  That is, time-varying confounders may be 
more relevant to mortality than to the other outcomes. 
Limitations 
There are other potential explanations for the observed association between wealth 
and these health outcomes.  Specifically, the weak association between wealth and 
hypertension was not anticipated.  The use of self-reported data about hypertension (and 
obesity) probably resulted in misclassification.  Hypertension was most likely underreported 
among younger respondents who have yet to be diagnosed with hypertension, but accurately 
reported among older individuals who were involved in the ongoing management of the 
condition (68).  Several studies have found that women, older and more educated individuals 
have less misclassification for self-reported hypertension than other groups (68-71).  Given 
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the relationship between wealth, age, education and health insurance status (the least wealthy 
tend to be younger, less educated and uninsured) we may have differential misclassification 
of hypertension.  In light of this misclassification bias, our data would reveal fewer 
hypertensives among the less wealthy, thus potentially explaining the attenuated results we 
see for this outcome.  Additional sensitivity analysis would be required to further explore the 
impact of the misclassification bias.  It should be noted, however, that other studies have 
found a weak association between hypertension and income, thus if wealth is expected to 
operate in a similar manner to income our result may not be wholly unexpected (65, 66).     
 The exclusion of baseline cases from the analysis raises questions about selection 
bias, another potential source of bias in this study.  Those with preexisting hypertension are 
more likely to be older and of lower SES.  By excluding them, the effect estimate will likely 
be biased downward.  That is, a sample of healthier, wealthier individuals will create an 
underestimate of the effect estimate for hypertension (75).  Modeling the probability of 
hypertension instead of the incidence will help address the concern of selection bias.  Table 
19 in the Appendix presents the model for the probability of hypertension.  Although the 
magnitude of effect is similar between the incidence and the probability models for 
hypertension (except for the risk ratio for the less than or equal to 0 group), the precision in 
the probability model is improved.  This suggests that the exclusion of baseline cases in the 
hypertension analysis results in a weaker association between wealth and hypertension.   
We should also point out the likely bias in the mortality findings resulting from 
attrition within the PSID.  Respondents who were lost to follow up were included in the 
analysis and censored at their last time point; however, their mortality status remained 
unknown.  If there was differential mortality between the censored and the uncensored 
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respondents, (it is feasible that censored individuals had higher mortality rates and were less 
wealthy) we would observe bias towards the null.  That is our results may be underestimating 
the real mortality risk.  PSID conducted an internal examination of the affects of attrition on 
mortality and found that the mortality status of 11% of a sample of persons lost to follow-up 
could not be determined and about 3% were actually deceased (85).  Overall the problem of 
attrition is significant in PSID.  Of the approximately 18,000 individuals in the sample in 
1968 only about 5000 were interviewed in 2001 (92).   
The findings related to the other health outcomes, smoking, obesity and general 
health status were all in the expected direction.  It should be noted, however, that the 
discussion of selection bias resulting from the exclusion of baseline cases applies to these 
health outcomes as well.  Specifically, the discussion in Chapter 5 examines selection bias in 
smoking more closely.  Furthermore, given that height and weight were self-reported, some 
misclassification of obesity was inevitable.  Thus the results presented in Chapter 5 are likely 
an underestimation of effect.      
Although MSM can produce a causal effect estimate, it should be noted that this 
holds only if certain assumptions are met.  The assumption of no unmeasured confounding, a 
prerequisite for producing causal estimates, is unlikely for this dissertation.  For example, 
health insurance status is arguably a potential confounder in the GHS-wealth and mortality-
wealth analyzes.  Unfortunately, health insurance data were not collected in early waves of 
the PSID.  Others may argue that our adjustment for baseline health status was not sufficient 
in the mortality-wealth analysis.  Other studies have used less crude measures to control for 
baseline health (48).  Furthermore, causality can only be inferred from observational data if 
the assumption of consistency holds.  That is the researcher can randomize participants to the 
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exposure, as is done in a randomized control trial.  Wealth, similar to other social factors, is 
not fully assignable.  Government policies, however, do play some role in the distribution of 
wealth in the US, thus it is not wholly unrealistic to conceptualize wealth as at least in part 
randomizable.  Therefore, we believe that the use of MSM in this dissertation improves upon 
past estimates, but must be seen in light of these caveats.    
Mechanisms 
The choice of the 3 CVD risk factors as health outcomes for this study was motivated 
primarily by our interest in the chronic stress pathway.  It has been hypothesized that chronic 
stress and other psychosocial factors trigger a series of biological events, through central 
nervous system activation of autonomic, neuroendocrine and immune responses (82).  Since 
wealth is a stockpile of financial resources, a lack of wealth (which translates into the 
absence of a safety net) is ostensibly a cause for financial stress.  The absence of wealth over 
time is thus a cause of chronic stress.  The lack of wealth among poor families may result in 
worries over immediate survival in the event of job loss or some other catastrophe, but 
among middle class families a lack of wealth, for example, may result in stress surrounding a 
family’s ability to save for higher education for their children.  The absence of wealth, 
therefore, is not stressful for poor families, but may weigh heavily on middle and upper class 
families as well.  
The biological pathways associated with the chronic stress hypothesis may be 
especially germane to hypertension and other cardiovascular functions (83).  In addition, 
smoking and weight gain may be mechanisms to cope with chronic stress for some 
individuals.  Thus they fall on the causal pathway from a lack of financial resources to 
cardiovascular disease.  Although they are not health outcomes per se, smoking and obesity 
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are important risk factors for a host of diseases and they are important in cultivating healthy 
environments and lifestyles. 
In addition, poor physical and social environments can encourage health damaging 
exposures (77).  For example, the lack of economic resources associated with having little 
wealth may limit an individual’s access to health care, quality housing and nutritious foods 
among other things.  A lack of economic and social resources can also result in insufficient 
investment in “human, physical, social and health infrastructure” which may be detrimental 
to the health of populations (78).  Assuming that less wealthy individuals live in less wealthy 
communities, insufficient infrastructure may take the form of fewer or less convenient public 
transportation options, a lack of parks and unsafe streets, and more liquor and convenient 
stores.  These deficiencies can then lead to increased isolation, a more sedentary lifestyle and 
poor diets, which directly result in higher rates of smoking and obesity among less wealthy 
individuals (79, 80).  Other research has found that low SES individuals may have less social 
support, higher job strain and less job control.  All these factors have been associated with 
higher rates of smoking and obesity (81).   
 Poor general health status may result from several of the above mentioned pathways.  
For example, a lack of economic resources may result in poor access to health care which 
may in turn result in poor health status.  The general health status variable may also be 
capturing a host of other health problems which result from poor physical and social 
environments.  Given its lack of specificity, several potential pathways could result in poor 
health status. 
The cumulative disadvantage literature seems most relevant to a discussion of wealth 
and mortality.  If posits that inequalities in SES worsen over the life course, resulting in 
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worse health outcomes for low SES individuals.  Therefore the effects of low SES over a 
lifetime are more likely to be seen with an outcome like mortality than a more proximal one.  
The other health outcomes, smoking, obesity, hypertension and GHS, all show stronger 
effects among the poor. Since these factors contribute to mortality, the pathways through 
which they function may also be acting on mortality. 
Policy Implications 
 Most government policy to date has focused on improving the income of poor 
families.  Programs such as Temporary Assistance for Needy Families (TANF), food stamps, 
section VIII housing subsidies and the earned income tax credit are all directed towards 
helping poor families augment resources for consumption.  About 40% of low income 
families own homes and have other assets, such as savings accounts.  Thus policies that focus 
on increasing wealth may further assist low income families to find financial stability.   
Many current policies discourage low income families from asset building.  For 
example, the tax exemption for mortgage interest on homes is targeted mainly at middle and 
upper income families.  Low income families who pay little to no income tax do not benefit 
from it.  In addition, for those families who receive housing subsidies, purchasing a home 
would result in the loss of this benefit thus further discouraging low income families to buy a 
home.  Furthermore, many current income assistance programs, such as TANF and food 
stamps, have asset restrictions.  Families wishing to save money may lose these benefits if 
their savings were beyond a certain amount; yet another disincentive for poor families to 
build assets. 
In recent years, the advent of individual development accounts (IDA) is a possible 
avenue to assist low income families with asset building.  IDAs are restricted savings 
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accounts, where withdrawals must be used for specific purposes such as home ownership, 
education or to start a business.  Upon withdrawal (for a sanctioned purpose) funds are 
matched by state and federal governments.  As of 2003, on average funds were being 
matched with $2 for each dollar invested by the account holder for a maximum of $13,000 
eligible for matching (93).   As of 2007, 37 states plus the District of Columbia and Puerto 
Rico had enacted an IDA programs (94).   Although IDAs are a relatively new asset building 
tool, thus far an important lesson learned from IDAs is that low income families can indeed 
save money.   
Future directions 
The study of wealth’s impact on health still remains relatively unexplored.  In 
addition to the health outcomes presented here, several other health outcomes would be 
worthy of exploring.  Specifically CVD outcomes such as stroke and heart attacks as well as 
CVD-specific mortality would be of interest within the context of the chronic stress pathway.  
Several large studies with good wealth measures, PSID included, have expressed interest in 
collecting biomarker data.  The association between well measured clinical health outcomes 
and wealth (from the PSID or other sources) could prove a useful addition to this literature. 
In addition to assessing other health outcomes, certain populations may benefit more 
for the study of wealth and health than others.  As indicated by past research, the elderly and 
unemployed are populations in which the use of wealth would be useful.  For example, from 
these results we see little benefit from using wealth in minority populations.  Given the very 
low levels of wealth among black and Hispanic families, wealth may not be a useful measure 
of SES in studies that focus on these groups.   
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Furthermore, in light of the tremendous inequality in wealth in America the study of 
wealth inequality may yield robust and interesting findings.  Several measures of wealth 
inequality could be ascertained.  Similar to the income inequality literature, the Gini 
coefficient or Robin Hood Index could be used to ascertain wealth inequality.  Compared to 
the research looking at income inequality and health, wealth inequality may yield far more 
decisive results.  In addition, recent work on the concept of relative deprivation could prove 
to be well suited for a measure like wealth (95). 
Conclusions 
Future health research may benefit from the use of wealth as an additional measure of 
SES.  As discussed earlier, wealth has many advantages relative to other SES measures.  If 
health research can incorporate an effective yet concise way to measure wealth, the 
limitations of using wealth in health research may be more easily overcome.  Forthcoming 
work by Cubbin and colleagues, hopes to present one way to effectively measure wealth in 
health research (13).  Alternatively, improving the health measures included in social science 
surveys that already measure wealth effectively would be an alternate source of data for 
epidemiologists to use.  In addition, wealth may provide better control for SES than income, 
education or occupation.  This is critical in ensuring that future health research effectively 
controls for the powerful confounding effects of SES when exploring additional exposure-
disease relationships.  Poor control for SES may lead to overestimated results and misleading 
conclusions. 
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Appendix   
Table 17. Risk ratios and 95% confidence intervals from traditional models (non-MSM) for CVD outcomes, 
PSID 1999 - 2005 
 Obesity Smoking Hypertension 
 risk 
ratio 
Lower 
95% 
CI 
Upper 95% 
CI 
risk 
ratio 
Lower 
95% 
CI 
Upper 
95% 
CI 
risk ratio Lower 
95% 
CI 
Upper 
95% 
CI 
≤  zero 
wealth 
1.71 1.37 2.14 2.10 1.46 3.01 1.17 0.96 1.42 
Quintile 1 1.74 1.39 2.17 1.58 1.09 2.30 1.25 1.02 1.52 
Quintile 2 1.51 1.22 1.85 1.59 1.11 2.27 1.24 1.03 1.48 
Quintile 3 1.54 1.27 1.87 1.42 1.00 2.01 1.17 0.99 1.39 
Quintile 4 1.36 1.13 1.64 1.30 0.93 1.82 1.17 1.01 1.36 
Quintile 5 Referent   Referent   Referent   
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Table 18. Risk ratios and 95% confidence intervals from traditional models (non-MSM) for general health 
status and mortality, PSID 1984 - 2005 
 General Health Status Mortality 
 
Risk 
ratio 
Lower 
95% CI 
Upper 
95% CI 
Risk 
ratio 
Lower 
95% CI 
Upper 
95% CI 
≤  0 wealth 1.70 1.44 1.99 1.32 1.07 1.63 
Quintile 1 1.48 1.27 1.73 1.07 0.87 1.31 
Quintile 2 1.25 1.08 1.45 1.16 0.97 1.40 
Quintile 3 1.23 1.07 1.41 1.08 0.91 1.28 
Quintile 4 1.18 1.04 1.34 1.00 0.85 1.16 
Quintile 5 Referent   Referent   
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Table 19. Prevalence and incidence models for hypertension, PSID 1999-2005 
 Prevalence model Incidence model 
 Risk 
ratio 
Lower 95% CI Upper 95% CI Confidence 
Limit Ratio 
Risk 
ratio 
Lower 
95% CI 
Upper 
95% CI 
Confidence 
Limit Ratio 
≤  0 
wealth 1.26 1.14 1.40 1.23 1.13 0.91 1.40 1.54 
Quintile 1 1.21 1.10 1.34 1.22 1.23 0.99 1.52 1.54 
Quintile 2 1.19 1.08 1.30 1.21 1.22 1.00 1.49 1.49 
Quintile 3 1.16 1.06 1.26 1.19 1.16 0.96 1.39 1.45 
Quintile 4 1.07 1.00 1.15 1.16 1.07 0.92 1.26 1.37 
Quintile 5 Referent    Referent    
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